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INTRODUCTION 
Obesity has been cited as the known health hazard of our 
time and the dangers of being overweight have come to be 
increasingly recognized particularly during the last forty 
years. There is a linear relationship between the degree of 
obesity and excess mortality and morbidity (Lew and Garfinkel 
1979, Waaler 1983). However, it is not the obesity itself 
which provokes a high degree of morbidity and mortality, but 
the large range of metabolic disorders to which many obese 
people are susceptible. A 12-year follow-up study by the 
American Cancer Society shows that persons who are greater 
than 40% overweight suffer increased mortality from diabetes, 
coronary heart disease, and some cancer (Lew and Garfinkel 
1979). The importance of less severe obesity has remained 
controversial in that moderate obesity is not associated with 
increased mortality (Andres 1980, Harrison 1985, Keys 1980). 
Obesity is defined as that physiological state in which 
there is excessive accumulation of body fat in both the 
absolute and the relative sense (McBride 1964). This state 
results from the excessive intake of energy relative to energy 
expenditure caused by genetic, metabolic, endocrinological, 
environmental, or behavioral factors or hypothalamic injury 
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(Bray and York 1979). The endocrine aspects of obesity have 
assumed a prominent place in consideration of the 
pathogenesis, diagnosis, prognosis, and treatment of obesity 
(Glass 1989). Several metabolic changes accompany obesity 
such as hyperinsulinemia (Beard et al. 1987, Cohen et al. 
1986, Genuth 1973), insulin resistance (Cohen et al. 1986, 
Kolterman et al. 1980, Zuniga-Guajardo et al. 1986), reduced 
growth hormone level (Meistas et al. 1982, Slavnov and Epstein 
1977) and blunted growth hormone responsiveness to stimulation 
(Davies et al. 1985, Kopelman and Noonan 1986), increased 
Cortisol turnover with normal serum levels (Abou-Samra et al. 
1985, Kopelman et al. 1988, Kurtz et al. 1987, Strain et al. 
1982), elevated parathyroid hormone level (Anderson et al. 
1986, Bell et al. 1985), increased serum epinephrine (Schwartz 
et al. 1980), and decreased (Burman et al. 1980, Chomard et 
al. 1985, Kventy 1985) or normal (Bray et al. 1973, Strata et 
al. 1978) thyroid hormone metabolism. The failure of these 
abnormalities to be normalized after weight reduction raises 
the possibility of an underlying disorder leading to both 
endocrine dysfunction and obesity, rather than to the 
endocrine dysfunction being a consequence of the obesity. 
Thyroid hormone is required for normal growth and tissue 
development and is an important regulator of energy 
metabolism. A number of disease states is associated with 
altered thyroid hormone metabolism and action. Decreased 
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concentrations of thyroid hormones in plasma are found in a 
high percentage of diabetic (Schlienger et al. 1982) and obese 
patients (Bray et al. 1976) . Hypothyroidism, which is clearly 
associated with some types of obesity in humans and in animal 
models, precedes the onset of hyperinsulinemia, insulin 
resistance, hyperphagia, and obesity (York et al. 1978). 
The genetically obese (ob/ob) mouse is an excellent animal 
model in which to study the effect of thyroid hormone. These 
mice have a number of metabolic and endocrine disorders as 
early as 2 weeks of age, among which are depressed oxygen 
consumption (Kaplan and Leveille 1974), low body temperature 
(Joosten and Van der Kroon 1974), decreased thermogenic 
activity of brown adipose tissue (Goodbody and Trayhurn 1982), 
higher body fat content (Boissonneault et al. 1978), and 
hypothyroidism (Mobley and Dubuc 1979). These disorders 
persist throughout adulthood in obese mice. I reported that 
T3 treatment increased whole body O2 consumption in ob/ob mice 
(Oh and Kaplan 1989). However which metabolically important 
tissues are responsible for increased O2 consumption and what 
effects early T3 treatment has on concentrations of thyroid 
hormones, insulin, and glucose in serum and on possible 
changes in body composition are not yet known. 
This dissertation explores the role of thyroid hormone (T3 ,  
triiodothyronine) administration on oxidative metabolism in 
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ob/ob mice early in the development of obesity, before gross 
abnormalities of obesity are apparent. 
Explanation of dissertation format 
This dissertation contains an abstract, general 
introduction, literature review, two papers submitted for 
publication, general discussion and summary, and literature 
cited in general introduction, literature review, and general 
discussion and summary. 
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LITERATURE REVIEW 
The genetically obese hyperglycemic (ob/ob) mouse is 
extensively used as a model for the study of early onset 
obesity and mature onset diabetes in human. These ob/ob mice 
have a number of metabolic and endocrine disorders that can be 
detected as early as 2 weeks of age before the obesity is 
phenotypically expressed. These mice exhibit depressed oxygen 
consumption (Boissonneault et al. 1978, Kaplan 1981, Kaplan 
and Leveille 1974), low body temperature (Kaplan 1981, Kaplan 
and Leveille 1974), and higher body fat content (Boissonneault 
et al. 1978). Also, thyroid hormones are low during thermal 
stress in ob/ob mice (Bray and York 1971, Joosten and Van der 
Kroon 1974). Ohtake et al. (1977), however, reported that the 
thyroid-pituitary axis of ob/ob mice was normal and that 
hypothermia was not due to hypothyroidism. These mice showed 
decreased thermogenic activity of brown adipose tissue as 
measured by GDP binding to mitochondria, which was also 
detectable early, when obesity was not apparent (Goodbody and 
Trayhurn 1982, Himms-Hagen and Desautels 1978). Oxygen 
consumption of brown adipose tissue was lower in ob/ob than in 
non-ob/ob mice (Thurlby and Trayhurn 1980). Generally thyroid 
hormones potentiate the norepinephrine-stimulated GDP binding 
to brown adipose tissue mitochondria. This thermogenic 
activity is reduced in the brown adipose tissue of ob/ob mice 
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(Hiimns-Hagen 1983a, Hogan and Hiirans-Hagen 1981) . Also these 
mice maintain elevated levels of food intake over much of 
their adult life (Chlouverakis and White 1969). Dubuc (1976) 
reported that these mice, regardless of feeding regimen, 
maintained absolutely higher carcass fat levels than did their 
lean littermates. 
Thyroid hormone is required for normal growth and tissue 
development and is an important regulator of energy 
metabolism. Triiodothyronine (T3) is the metabolically active 
form of thyroid hormone and known to be 3 to 8 times more 
potent than thyroxine (T4). T3 also exerts negative feedback 
inhibition on TSH (thyroid stimulating hormone) secretion by 
the pituitary. Serum T3 plays a more important, direct role 
than does serum T4 in the feedback regulation of serum TSH in 
the euthyroid or mildly hypothyroid rats (Emerson et al. 
1989). Varied results in serum concentrations of thyroid 
hormones in ob/ob mice are reported (Ikeda et al. 1988, Kaplan 
et al. 1985, Mobley and Dubuc 1979, York et al. 1978), which 
were either lower or higher or the same as in non-ob/ob mice. 
Hypothyroidism was a very early lesion in ob/ob mice, 
possibly because of abnormal regulation of the hypothalamic-
pituitary-thyroid at early ages (Bray and York 1971). 
Insensitivity to the effect of circulating hormones by non-
thyroid tissues might be present at later ages (Mobley and 
Dubuc 1979, York et al. 1978). I reported that T3 treatment 
7 
increased animal oxygen consumption (Oh and Kaplan 1989). In 
that report, insulin-stimulated and non-insulin-stimulated 
glucose utilization in diaphragm of ob/ob mice was also 
increased by T3 treatment. The ob/ob mice required higher 
doses of T3 than did non-ob/ob mice to increase diaphragm 
glucose utilization. This was consistent with the concept of 
T3 resistance by the tissues. In studies with obese humans, 
T3 treatment increased the metabolic rate (Abraham et al. 
1985), decreased body weight, and increased serum T3 and TSH 
(Rozen et al. 1986). Wolman et al. (1985) reported that body 
weight loss after T3 treatment was from lean body mass rather 
than body fat. 
Thyroid hormones are low in the ob/ob mice during thermal 
stress of cold temperature (Bray and York 1971, Joosten and 
Van der Kroon 1974). The defects in thermogenesis in ob/ob 
mice may be attributed to impaired thyroid hormone action. 
Supportive of this concept are reports that the thyroid 
hormone-sensitive Na"^-K"^-ATPase is lower in the liver and 
skeletal muscle of ob/ob mice than in same tissues of non-
ob/ob mice (Lin et al. 1979, York et al. 1978a). Recently, 
Hillgartner and Romsos (1988) reported that the ob/ob mice had 
lower hepatic thyroid hormone uptake than non-ob/ob mice. 
This may account for the impaired thyroid hormone action and 
T3 production in the liver, which is the major site for T3 
production from T4. 
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Thyroid hormones are known to increase metabolic rate. 
Previously, I reported that T3 treatment increased animal 
oxygen consumption and both non-insulin-stimulated and 
insulin-stimulated glucose utilization in ob/ob mice and 
eliminated the insulin resistance by diaphragm muscles (Oh and 
Kaplan 1989). Others have shown that T3 treatment also 
increases anaerobic glycolysis in muscle (Nicole and Johnston 
1981). Skeletal muscle plays a major role in glucose 
utilization (DeFronzo et al. 1981, Katz et al. 1983). 
Significant amounts of energy are also used by the skeletal 
musculature (Martin and Fuhrman 1955). Because O2 consumption 
is lower in some muscles of ob/ob mice (Conway and Kaplan 
1977, Kaplan and Oh 1991), the role of T3 on muscle O2 
consumption was further explored. 
Thyroid hormones are known to increase fatty acid 
mobilization from adipose tissue in rat (Fain and Rosenthal 
1971). In ob/ob mice, the impaired norepinephrine-stimulated 
lipolysis was improved by exogenous thyroid hormone (Otto et 
al. 1976, Thenen and Carr 1978), but York et al. (1978b) 
reported that adipose tissue lipolysis of ob/ob mice was less 
sensitive to thyroid hormone than that of non-ob/ob mice. In 
preadipocyte cell lines from both ob/ob and non-ob/ob mice, T3 
increased both fatty acid synthesis and lipolysis (Pou and 
Torresani 1989). Thyroid hormones stimulate hepatic fatty 
acid synthesis and esterification in the rat (Diamant et al. 
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1972, Mariash et al. 1980). Also T3 treatment increased O2 
consumption in isolated perfused liver (Horst et al. 1989, 
Millier and Seitz 1980) and in isolated hepatocytes (Gregory 
and Berry 1991). Liver utilizes 30-40 % of the resting oxygen 
consumption (Martin and Fuhrman 1955) and therefore should be 
explored as a possible site for the increased total O2 
consumption in response to T3 .  
Past experiments used pharmacological doses of T3 for a 
short period of time. The experiments reported here in ob/ob 
mice explore the possibility that increasing the serum T3 
levels early in the development of obesity to physiological 
and pharmacological levels over a 3 week period, at a critical 
developmental period, will alter energy metabolism and reduce 
body fat. Food consumption was equalized across all groups to 
remove the role of hyperphagia per se on the parameters 
studied. The metabolic responses to thyroid hormones are 
different in many tissues (Barker and Klitgaard 1952, Schwartz 
1983). T3 treatment increased whole body oxygen consumption 
in ob/ob mice (Oh and Kaplan 1989, Oh and Kaplan 1993). Major 
metabolically important tissues should account for the change 
in whole body metabolism. Although a controversy exists about 
the role of brown adipose tissue in human obesity, in which 
brown adipose tissue is almost nonexistent, it is a 
thermogenically important tissue in ob/ob mice (Hogan and 
Himms-Hagen 1981). White adipose tissue is important in 
10 
energy balance and should also be explored in terms of 
oxidative metabolism. The present report explores the 
possibility that early T3 treatment of ob/ob mice over a 3 
week period will alter the energy expenditure of important 
metabolically active tissues. 
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PAPER I. EARLY TREATMENT OF OBESE (OB/OB) MICE WITH 
TRIIODOTHYRONINE INCREASES OXYGEN CONSUMPTION 
AND TEMPERATURE AND DECREASES BODY FAT CONTENT 
12 
ABSTRACT 
An early abnormality in the ob/ob mouse is a low 
circulating level of the thyroid hormone, triiodothyronine 
(T3) . The possibility was explored that early T3 treatment of 
ob/ob mice will increase oxidative metabolism and lower body 
fat content. Doses of T3, ranging from 0.0 to 25.0 jug/lOO g 
body weight (BW) were injected intraperitoneally into ob/ob 
and non-ob/ob mice daily from 3 weeks until 6 weeks of age. 
Food intake was equalized across all groups to that consumed 
by the non-ob/ob 0.154M NaCl (saline)-treated group. At 6 
weeks of age, the following parameters were analyzed: body 
weight, concentrations of T4, T3, TSH, insulin, and glucose in 
serum, oxygen consumption, colonic temperature, and body 
composition. T3 treatment decreased body weight, increased 
body oxygen consumption, increased colonic temperature, and 
decreased body fat without a significant change in body 
protein in ob/ob mice. T3 treatment also increased serum T3, 
decreased serum T4, TSH, insulin, and glucose concentrations 
in ob/ob mice. Because total body protein did not change as a 
result of T3 treatment, the increased oxidative metabolism due 
to T3 treatment was probably via the change of metabolic 
activity of the total lean body mass or the specific 
metabolically active tissues in the ob/ob mice. 
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Keywords obesity, triiodothyronine, oxidative metabolism, 
body composition, temperature 
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INTRODUCTION 
Genetically obese hyperglycemic (ob/ob) mice have a number 
of metabolic and endocrine disorders as early as 2 weeks of 
age and are a useful model of some types of human obesity. 
These mice exhibit depressed oxygen consumption (Boissonneault 
et al. 1978, Kaplan 1981, Kaplan and Leveille 1974), low body 
temperature (Kaplan 1981, Kaplan and Leveille 1974), and 
higher body fat content (Boissonneault et al. 1978). Thyroid 
hormones are also low during thermal stress of cold 
temperature (Bray and York 1971, Joosten and Van der Kroon 
1974). Ohtake et al. (1977), however, reported that thyroid-
pituitary axis of ob/ob mice was normal and that hypothermia 
was not due to hypothyroidism. Also, these mice maintain 
elevated levels of food intake over much of their adult life 
(Chlouverakis and White 1969). Dubuc (1976) reported that 
these mice, regardless of feeding regimen (ad lib. or 
restricted), maintained absolutely higher carcass fat levels 
than did their lean littermate. 
Thyroid hormone is required for normal growth and tissue 
development and is an important regulator of energy 
metabolism. Triiodothyronine (T3) is the metabolically active 
form of thyroid hormone and known to be 3 to 8 times more 
potent than T4. T3 also exerts negative feedback inhibition 
of thyroid stimulating hormone (TSH) secretion by the 
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pituitary. Serum T3 plays a more important, direct role than 
does serum T4 in the feedback regulation of serum TSH in the 
euthyroid or mildly hypothyroid rats (Emerson et al. 1989). 
Varied results in concentrations of thyroid hormones in serum 
of ob/ob mice are reported (Ikeda et al. 1988, Kaplan et al. 
1985, Mobley and Dubuc 1979, York et al. 1978), which were 
either lower or higher or the same as in non-ob/ob mice. 
Hypothyroidism is a very early detectable symptom in ob/ob 
mice, possibly because of abnormal regulation of the 
hypothalamic-pituitary-thyroid at early ages (Bray and York 
1971). Insensitivity to the effect of circulating hormones by 
non-thyroid tissues might be present at later ages (Mobley and 
Dubuc 1979, York et al. 1978). I reported that T3 treatment 
increased animal oxygen consumption (Oh and Kaplan 1989). In 
that report, insulin-stimulated and non-insulin-stimulated 
glucose utilization in diaphragm of ob/ob mice was also 
increased by T3 treatment. The ob/ob mice required higher 
doses of T3 than did non-ob/ob mice to increase diaphragm 
glucose utilization. This finding was consistent with the 
concept of T3 resistance by the tissues. In studies with 
obese humans, T3 treatment increased the metabolic rate 
(Abraham et al. 1985), decreased body weight, and increased 
serum T3 and TSH (Rozen et al. 1986). Wolman et al. (1985) 
reported that body weight loss after T3 treatment was from 
lean body mass rather than body fat. 
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Past experiments used pharmacological doses of T3 for a 
short period of time. The experiments reported here in ob/ob 
mice explore the possibility that increasing the serum T3 
levels early in the development of obesity to both 
physiological and pharmacological levels over a 3-week period 
between 3 and 6 weeks of age, which is a critical 
developmental period, will alter energy metabolism and reduce 
body fat. Food consumption was equalized across all groups to 
remove the effect of hyperphagia per se on the parameters 
studied. Hyperphagia can possibly change sympathetic nervous 
system activity, hormonal status of insulin, epinephrine, and 
glucocorticoids, increase body fat tissues (Bray 1991). 
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MATERIALS AND METHODS 
Animals and Diets. Male obese (C57BL/6J-ob/ob) mice and 
their nonobese (non-ob/ob) littermates were obtained at 2 
weeks of age from the animal colony of the Food Science and 
Human Nutrition department of Iowa State University. At 2 
days of age, litter size was adjusted to 7-9 mice per litter 
to allow pups to even access to nurturing female mouse. 
Oxygen consumption was measured at 16 days of age on the basis 
of the low oxygen consumption exhibited by future obese mice 
(Kaplan and Leveille 1974). In this study, 2000 nl 02/hr g 
body weight at STP was used as the value below which 2-week-
old mouse pups are identified as obese with 99.9% reliability 
(the average value of O2 consumption is 2322.0 for non-ob/ob 
and 1439.9 /Lil/hr-g BW for ob/ob mice). All mice were housed 
individually in solid bottom plastic cages with aspen wood 
shavings for bedding in an animal room at 23 ± 1°C with a 12-
hour dark-light cycle (dark cycle 0600-1800 hr, light cycle 
1800-0600 hr). All mice were fed a high carbohydrate diet 
during the 6-hour feeding period from 1000 to 1600 hr and 
allowed free access to tap water. The diet consisted of: 
casein, 20.0 g; DL-methionine, 0.3 g; AIN mineral mix 76^, 3.5 
g; AIN vitamin mix 76^, 1.0 g; choline chloride, 0.2 g; corn 
oil, 5.0 g; fiber, 5.0 g; dextrose, 60.0 g; and dextrin, 5.0 g 
per 100 g diet. The diet was pelleted to facilitate the 
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measurement of food consumption. Food intake was equalized 
daily across all groups to the average consumed by non-ob/ob 
saline-treated group on the previous day. Food consumption 
and body weight were measured daily until 6 weeks of age. 
Mice were treated with L-triiodothyronine(T3) as indicated 
below. 
Treatments. Obese and nonobese mice were divided into 7 
groups. Six levels of 2.5, 5.0, 7.5, 10.0, 12.5, and 25.0 /ig 
L-T3/IOO g BW, dissolved in 0.154M NaCl (saline) (final pH 9.1 
to keep the T3 soluble), were injected intraperitoneally 
daily, between 0900 and 1000 hr from 3 to 6 weeks of age. 
Untreated ob/ob and non-ob/ob mice were injected with saline, 
pH 9.1. Body weight was measured daily at the time of the 
treatment. Oxygen consumption, colonic temperature, and final 
body weight were measured at 6 weeks of age. 
Oxygen Consumption. All measurements of 03 consumption 
were conducted in the animal room. O2 consumption was 
measured before treatment and at 6 weeks of age by 
differential constant pressure respirometry as reported 
(Kaplan and Leveille 1974) with the apparatus submerged in a 
water bath at 25°C. Duplicate measurements were made 
consecutively for each mouse. Oxygen consumption was 
corrected to standard temperature and pressure. 
Colonic Temperature. Colonic temperature was measured 
immediately after removal of the mouse from the chamber, in 
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which O2 consumption was measured, by using a thermistor with 
a round tip applicator (YSI model 43TA single-channel tele-
thermometer, Yellow Springs Instrument Co., Yellow Springs, 
OH). Each mouse was held in a mouse restrainer, and the 
applicator was inserted about 1 cm into the rectum and held 15 
seconds until the needle of the meter was stabilized. 
Body Composition. The contents inside the gastrointestinal 
tracts were removed as much as possible from mice, and the 
carcasses were stored at -20°C for future analysis. Each 
frozen carcass was chopped into small pieces and homogenized 
by using a one quart size Waring blender with addition of 
sufficient (approximately 100 ml) water so that the blender 
could operate freely. The entire homogenate was transferred 
into a pre-weighed dry flask, frozen at -20°C, and 
subsequently lyophilized. Lyophilized samples were weighed 
and stored desiccated at 4°C until analysis for protein and 
fat. For the protein determination, weighed samples were 
digested in 3 6N H2SO4, 0.3% Se02 by using the digestion system 
(Tecator ab, Hoganas, Sweden) at 420°C for 1 hr or until 
heated samples were clear. The resultant (NH4)2S04 was 
determined colorimetrically (Chaney and Marbach 1962), and the 
protein factor of 6.25 was used in calculation. Lipid was 
extracted from weighed samples by chloroform-methanol (2:1, 
v/v) and determined gravimetrically (Griminger and Gamarsh 
1972) . 
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Serum Analysis. At 6 weeks of age, all mice were killed by 
decapitation between 0930 and 1000 hr, which was prior to the 
start of the feeding period. Blood was collected in 
microcentrifuge tubes, allowed to clot, and centrifuged. 
Serum was collected and saved frozen at -20"C until analysis 
for triiodothyronine (T3), thyroxine (T4), thyroid stimulating 
hormone (TSH), insulin, and glucose. Because very small 
volume of serum was collected from one mouse, sera from three 
mice were pooled to create each sample in the assay. Also, 
serum assay was performed last after a few sets of experiments 
to create enough sample numbers in a group. Serum T3,  T4,  
TSH, and insulin were assayed by using radioimmunoassay (RIA) 
procedures as described in the RIA kits: Amerlex-M T4,  
Amerlex-M T3, TSH coated tube assay, and insulin RIA kit, 
respectively (Amersham, Arlington, IL). Serum glucose was 
assayed by using glucose hexokinase reagent kit (Sigma 
Chemical Co., St. Louis, MO) in which glucose was assayed by 
using the coupled enzymatic reactions catalyzed by hexokinase 
and glucose-6-phosphate dehydrogenase (Bondar and Mead 1974). 
Chemicals. L-3,3•,5-triiodothyronine was purchased from 
Calbiochem-Behring Co. (La Jolla, CA). All RIA kits were 
purchased from Amersham (Arlington, IL). The glucose 
hexokinase reagent kit was purchased from Sigma Co. (St. 
Louis, MO). All other reagents were purchased from Fisher 
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Scientific Co. (Fair Lawn, NJ). Diet ingredients were 
purchased from ICN Biomedicals (Costa Mesa, CA). 
Statistics. Overall statistical significance was 
determined by analysis of variance (Ray 1982, Snedecor and 
Cochran 1980). Main effects include T3 treatment and 
phenotype. Significant main effects and interactions were 
identified, and means within these main effects were tested 
with the protected t-test, which uses the mean square of the 
error term from the ANOVA. 
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RESULTS 
Body weight and food consumption. At 6 weeks of age, no 
significant differences in body weight between ob/ob and non-
ob/ob mice in saline-treated groups were observed (Fig. 1). 
T3 treatment decreased body weight in both phenotypes but 
decreased more in ob/ob mice. Total food consumption during 
the experimental period was similar in both phenotypes because 
food was equalized across all ob/ob and non-ob/ob groups 
throughout the experimental period (Table 1). The average 
weekly food consumption in all groups were 8.3 g (4 weeks), 
17.1 g (5 weeks), and 21.7 g (6 weeks). 
Serum concentrations of insulin and glucose. No 
significant differences in serum insulin and glucose were 
observed between saline-treated ob/ob and non-ob/ob mice (Fig. 
2). T3 treatment decreased serum insulin and glucose in both 
phenotypes. Serum glucose was significantly decreased at all 
doses of T3. 
Serum concentrations of TSH, T4, and T3. Serum TSH was 
higher in saline-treated ob/ob mice than saline-treated non-
ob/ob mice (Fig. 3). T3 treatment significantly decreased 
serum TSH at 2.5 /xg T3/IOO g BW to the level observed in non-
ob/ob mice. The highest dose of T3 (25.0 ^g/100 g BW) reduced 
the ob/ob TSH values even further. T3 did not affect serum 
TSH in non-ob/ob mice. Serum T4 was lower in saline-treated 
FIGURE 1 Body weight of ob/ob and non-ob/ob mice at 6 weeks 
of age. The mice were treated with T3 from 3 to 6 weeks of 
age as outlined in Materials and Methods. Values are the 
means ± SEM for 8-9 mice per group. Mean square error is 
3.97. Significant differences between means were determined 
by using the protected t-test. ^significantly different from 
0.0 fig T3 at P < 0.05, **significantly different from 0.0 fig 
T3 at P < 0.001. 
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TABLE 1 
Total food intake of ob/ob and non-ob/ob mice during the T3 
treatment period^ 
Treatment non-ob/ob ob/ob 
ng T3/100 g BW 
0 . 0  
2.5 
5.0 
7.5 
10.0 
12.5 
25.0 
48.9 
44.1 
46.7 
47.7 
46.9 
48.3 
46.1 
0.9 
1.1 
0.9 
1.1 
0 . 8  
1.0 
0 . 8  
g/3 weeks 
47.9 
46.6 
46.0 
47.4 
47.5 
47.7 
47.4 
0.7 
1.4 
1.9 
1.1 
1.1 
1.1 
0.7 
^Values are the means ± SEM for 7-9 mice per group. The 
mice were treated with T3 from 3 to 6 weeks of age as outlined 
in Materials and Methods. 
FIGURE 2 Serum insulin and glucose concentrations of ob/ob 
and non-ob/ob mice. The mice were treated with T3 from 3 to 6 
weeks of age as outlined in Materials and Methods. Values are 
the means ± SEM of 8-12 samples. Sera from 3 individual mice 
were pooled to create each sample. For insulin, the ANOVA 
showed a significant T3 effect at P < 0.0001. For glucose, 
the ANOVA showed significant T3 effect at P < 0.0001 and 
phenotype effect at P < 0.0001. Mean square errors for 
insulin and glucose are 311.04 and 461.61, respectively. 
Significant differences between means were determined by using 
the protected t-test. *significantly different from 0.0 /xg T3 
at P < 0.05, **significantly different from 0.0 fig T2 at P < 
0.005, ***significantly different from 0.0 ^g T3 at P < 0.001, 
"^significantly different from non-ob/ob at P < 0.05. 
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ob/ob mice (Fig. 3). All doses of T3 significantly decreased 
serum T4 in both phenotypes. No differences in serum T4 
levels were observed in T3-treated ob/ob and non-ob/ob mice. 
Serum T3 was lower in saline-treated ob/ob mice (Fig. 3). T3 
treatment increased serum T3 significantly in ob/ob mice even 
at the 2.5 fJLg T3/IOO g BW dose. Only the highest dose of T3 
(25.0 jLtg/lOO g BW) increased serum T3 values in non-ob/ob 
mice. The levels of serum T3 attained by exogenous injection 
of T3 were all within or near the physiological range. Serum 
T3 levels of ob/ob mice were more sensitive to the exogenous 
source of T3 than were the non-ob/ob mice. 
Body oxygen consumption and colonic temperature. Because 
the mode of expression of oxygen consumption has been debated 
over the years, more than one manner of expressing animal 
oxygen consumption was calculated. These were fil of O2 
consumed per hour in the basis of whole animal or g^'^S body 
weight or g^'^S body protein. Values of whole body oxygen 
consumption per animal in saline-treated ob/ob mice were 
approximately 67% of the values observed in non-ob/ob mice 
(Fig. 4). T3 treatment significantly increased O2 consumption 
in ob/ob mice while values in the non-ob/ob did not change 
with T3 treatment. Obese mice treated at the 25.0 nq T3 level 
had O2 consumption values that were approximately the same as 
observed in saline-treated non-ob/ob mice. 
FIGURE 3 Serum concentrations of TSH, T4, and T3 of ob/ob 
and non-ob/ob mice. The mice were treated with T3 from 3 to 6 
weeks of age as outlined in Materials and Methods. Values are 
the means ± SEM for 8-12 samples. Sera from 3 individual mice 
were pooled to create each sample. For TSH, the ANOVA showed 
significant T3 effect at P < 0.0001 and T3 x phenotype effect 
at P < 0.0069. For serum T4, the ANOVA showed significant T3 
effect at P < 0.0001, phenotype effect at P < 0.0001, and T3 x 
phenotype effect at P < 0.0001. For serum T3, the ANOVA 
showed significant T3 effect at P < 0.0001 and T3 x phenotype 
effect at P < 0.0148. Mean square errors for TSH, T4, and T3 
are 0.0003855, 24.02, and 1.25 respectively. Significant 
differences between means were determined by using the 
protected t-test. *significantly different from 0.0 ng T3 at 
P < 0.05, **significantly different from 0.0 jug T3 at P < 
0.025, ***significantly different from 0.0 /xg T3 at P < 0.001, 
•^significantly different from non-ob/ob at P < 0.001. 
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FIGURE 4 Oxygen consumption per animal in ob/ob and non-
ob/ob mice. The mice were treated with T3 from 3 to 6 weeks 
of age as outlined in Materials and Methods. Values are the 
means ± SEM for 9 mice per group. The ANOVA showed 
significant T3 effect at P < 0.0015 and phenotype effect at P 
< 0.0001. Mean square error is 8.10. Significant differences 
between means were determined by using the protected t-test. 
*significantly different from 0.0 /xg T3 at P < 0.005, 
"^significantly different from non-ob/ob at P < 0.001. 
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Oxygen consumption per of body weight was lower in 
saline-treated ob/ob than in saline-treated non-ob/ob mice 
(Fig. 5). T3 treatment significantly increased O2 consumption 
of ob/ob mice, even at the lowest dose. At 7.5 ng/100 g BW 
treatment level, differences between ob/ob and non-ob/ob were 
no longer observed. The same data are presented in Figure 6 
per gO'75 of body protein. On a per protein basis, the 
saline-treated ob/ob had a lower O2 consumption than the 
saline-treated non-ob/ob mice, although these differences were 
not statistically significant. In the Tg-treated ob/ob and 
non-ob/ob mice, no differences in O2 consumption on a whole 
body protein basis were found. T3 treatment significantly 
increased O2 consumption only in ob/ob mice at the highest 
levels of T3. 
Colonic temperature was lower in saline-treated ob/ob than 
in saline-treated non-ob/ob mice (Fig. 7). T3 treatment 
increased the colonic temperature in ob/ob mice. At the 10.0 
fig T3/IOO g BW and higher doses, colonic temperature were 
similar between ob/ob and non-ob/ob mice. 
Body composition. Total body protein in ob/ob mice was 
less than that in non-ob/ob mice in both saline-treated and 
Tg-treated groups (Fig. 8). Total body lipid in ob/ob mice 
was higher than that in non-ob/ob mice in all treatment 
groups. T3 treatment did not significantly offset body 
protein content. At 10.0 nq T3/IOO g BW and higher doses, T3 
FIGURE 5 Oxygen consumption per unit of body weight in 
ob/ob and non-ob/ob mice. The mice were treated with T3 from 
3 to 6 weeks of age as outlined in Materials and Methods. 
Values are the means ± SEM for 9 mice per group. The ANOVA 
showed significant T3 effect at P < 0.0001, phenotype effect 
at P < 0.0001, and T3 x phenotype effect at P < 0.0300. Mean 
square error is 60963.84. Significant differences between 
means were determined by using the protected t-test. 
*significantly different from 0.0 /xg T3 at P < 0.025, 
"'"significantly different from non-ob/ob at P <0.05. 
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FIGURE 6 Oxygen consumption per unit of body protein in 
ob/ob and non-ob/ob mice. The mice were treated with T3 from 
3 to 6 weeks of age as outlined in Materials and Methods. 
Values are the means ± SEM for 9 mice per group. The ANOVA 
showed a significant T3 effect at P < 0.0029. Mean square 
error is 1585590.12. Significant differences between means 
were determined by using the protected t-test. *significantly 
different from 0.0 nq T3 at P < 0.05. 
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FIGURE 7 Colonic temperature of ob/ob nad non-ob/ob mice. 
The mice were treated with T3 from 3 to 6 weeks of age as 
outlined in Materials and Methods. Values are the means ± SEM 
for 10 mice per group. ANOVA showed significant T3 effect at 
P < 0.0025, phenotype effect at P < 0.0001, and T3 x phenotype 
effect at P < 0.0002. Mean square error is 0.39. Significant 
differences between means were determined by using the 
protected t-test. ^significantly different from non-ob/ob at 
P < 0.01. 
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FIGURE 8 Total body protein, lipid, and water of ob/ob and 
non-ob/ob mice. The mice were treated with T3 from 3 to 6 
weeks of age as outlined in Materials and Methods. Values are 
the means ± SEM for 8 mice per group. For total protein, the 
ANOVA showed a significant phenotype effect at P < 0.0001. 
For total lipid, the ANOVA showed significant phenotype effect 
at P < 0.0001 and T3 x phenotype effect at P < 0.0157. For 
total water, the ANOVA showed a significant phenotype effect 
at P < 0.0001. Mean square errors for protein, lipid and 
water are 0.35, 0.97, and 1.07 respectively. Significant 
differences between means were determined by using the 
protected t-test. *significantly different from 0.0 fig T3 at 
P < 0.05, ^significantly different from non-ob/ob at P < 
0.001. 
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treatment significantly decreased body fat in ob/ob mice. 
Total body water in ob/ob mice was lower than in non-ob/ob 
mice in all groups (Fig. 8). T3 decreased body water only in 
non-ob/ob mice at 7.5 jug T3/100 g BW and higher levels. 
Percent lipid per unit of dry carcass weight in ob/ob mice was 
higher than that in non-ob/ob mice in all groups (Fig. 9). 
Only at the highest dose of T3 (25.0 /ug T3/IOO g BW) did T3 
treatment significantly decrease the percent lipid in ob/ob 
mice. Percent body protein per unit of dry carcass weight in 
ob/ob mice was lower than that in non-ob/ob mice (Fig. 9). 
However, T3 treatment significantly increased the percent 
protein in ob/ob mice at 5.0 /ig T3/IOO g BW and higher levels. 
FIGURE 9 Percent protein and lipid on a dry weight basis in 
ob/ob and non-ob/ob mice. The mice were treated with T3 from 
3 to 6 weeks of age as outlined in Materials and Methods. 
Values are the means ± SEM for 8 mice per group. For percent 
lipid, the ANOVA showed a significant phenotype effect at P < 
0.0001. For percent protein, the ANOVA showed a significant 
phenotype effect at P < 0.0001. Mean square errors for % 
lipid and % protein are 55.63 and 97.70 respectively. 
Significant differences were determined by using the protected 
t-test. *significantly different from 0.0 ng T3 at P < 0.01, 
^significantly different from non-ob/ob at P < 0.001. 
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DISCUSSION 
In genetically obese hyperglycemic (ob/ob) mice, the early 
periods of life, prior to gross deposition of fat, are 
probably critical to the development of the obese syndrome. 
Genetic differences in some aspects of metabolism probably are 
present early and cause abnormal physiological function and 
subsequent expression of the phenotype. I propose that this 
critical period might be between 3 weeks of age, immediately 
after weaning, and 6 weeks of age when the obese phenotype is 
easily detectable by visual inspection. The saline-treated 
ob/ob mice in these experiments clearly showed lower oxygen 
consumption, lower body temperature, lower concentrations of 
thyroid hormones, T4 and T3, and higher body fat at 6 weeks of 
age. These findings are consistent with past reports (Dubuc 
1976, Joosten and Van der Kroon 1974, Kaplan 1981). A low 
metabolic rate (Kaplan 1974) in preweaning ob/ob mice may be 
the result of a reduction in circulating thyroid hormones 
(Mobley and Dubuc 1979). 
T3 treatment increased circulating T3 levels in the ob/ob 
mice to within the normal range (1.0-3.0 nmol/L). In the 
results reported here, T3 treatment significantly increased 
animal oxygen consumption, increased body temperature, and 
decreased body fat of young ob/ob mice without a change in 
total body protein. No differences were found in the body 
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weight of ob/ob mice and non-ob/ob mice in all groups mainly 
because of equalized food consumption to prevent gross obesity 
in ob/ob mice during experimental periods (Fig. 1). T3 
treatment decreased body weight in both phenotypes. Higher T3 
doses had a greater effect on preventing weight gain in the 
ob/ob than in non-ob/ob mice. A weight loss in ob/ob mice 
after T3 treatment was previously reported by us (Oh and 
Kaplan 1989) as well as by others (Thenen and Carr 1980, York 
et al. 1978). 
Serum insulin and glucose concentrations in saline-treated 
ob/ob mice and non-ob/ob mice were similar (Fig. 2). Values 
reported here are different from the reported hyperglycemia 
and hyperinsulinemia in ob/ob mice (Bray and York 1971). In 
this experiment, food consumption was equalized across all 
groups which may account for differences from other reports in 
which the ob/ob mice were hyperphagic. Dubuc (1976) reported 
higher serum glucose and insulin in ob/ob mice, which were 
allowed free access to food and were hyperphagic, than non-
ob/ob mice. T3 treatment significantly decreased serum 
insulin and glucose in both phenotypes, but greater degree in 
ob/ob mice. Serum glucose was significantly decreased in both 
phenotypes in a dose-dependent manner. Thenen and Carr (1980) 
reported that T4 treatment lowered blood glucose in the ob/ob 
mice, but the hyperinsulinemia persisted. The differences in 
my results were probably due to the feeding regimen, which was 
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restricted. The food restriction itself in the ob/ob mice 
might cause a decrease in serum insulin in the saline-treated 
ob/ob mice. 
Serum T3 and T4 were lower and serum TSH was higher in 
saline-treated ob/ob mice (Fig. 3). The high TSH levels of 
the ob/ob mice were probably related to the low T4 and T3 
levels. Pituitary secretion of TSH is regulated by negative 
feedback control by T4 and T3 (Larsen 1982). The output of 
TSH by the pituitary is the principal factor modifying thyroid 
activity. T3 treatment significantly decreased serum TSH at 
2.5 nq T3/IOO g BW in ob/ob mice to the level of saline-
treated non-ob/ob mice. However, T3 treatment did not change 
serum TSH in non-ob/ob mice. This result suggests that 
exogenous T3 causes negative feedback regulation of TSH 
secretion from the pituitary in ob/ob mice. Although serum 
TSH in saline-treated ob/ob mice was higher, it did not appear 
to trigger thyroid gland production of more T3 or T4, which 
suggests a defect in the pituitary-thyroid axis in ob/ob mice. 
T3 treatment significantly decreased serum T4 in both 
phenotypes at all doses of T3, which was expected, because T3 
imposes negative feedback regulation on the pituitary-thyroid 
axis, probably at the level of the thyroid gland. This 
finding is consistent with the reported suppression of serum 
T4 by injected T3 (Bray and Ohtake 1976) . 
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Other investigators report that food restriction decreased 
serum T3 in ob/ob mice (Himms-Hagen 1985) and in obese men 
(Katzeff et al. 1990, Rozen et al. 1986). York et al. (1978) 
reported that ob/ob mice had lower T4 but normal T3. The low 
T3 found in this experiment may be due to food restriction. 
Oxygen consumption in saline-treated ob/ob mice was lower 
than that in saline-treated non-ob/ob mice regardless of the 
different modes of expression (Fig. 4, 5). Whole animal 
oxygen consumption expressed on a body protein basis was lower 
in saline-treated ob/ob than in non-ob/ob mice (Fig. 6), but 
these differences were not statistically significant. Kaplan 
(1981) reported that the ob/ob mice showed a lower O2 
consumption on a protein basis than non-ob/ob mice when 
animals were fed with free access to food. T3 treatment 
increased O2 consumption in ob/ob mice. Wimpfheimer et al. 
(1979) reported that hypothyroid rats had enhanced sensitivity 
to T3 by increasing O2 consumption. Also, the metabolic rate 
was increased by T3 treatment in obese men (Abraham et al. 
1985) which are all consistent with the results reported here. 
obese mice showed a low body temperature at an early age, 
even before weaning. This symptom persists after weaning 
through all developmental stages of obesity. At 6 weeks of 
age, saline-treated ob/ob mice had a lower colonic temperature 
than did non-ob/ob mice. This difference disappeared after T3 
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treatment (Fig. 7). The increase in body temperature is 
matched with the increase in body oxygen consumption. 
The change in body composition may influence the whole body 
metabolism. The saline-treated ob/ob mice showed higher total 
fat and lower total protein than non-ob/ob mice (Fig. 8). 
Because muscle tissues are metabolically more active than 
adipose tissues, this abnormally low ratio of protein to 
adipose mass can explain the lower O2 consumption in the ob/ob 
mice. T3 treatment decreased total fat content in a dose-
dependent manner but did not significantly change total 
protein, even though it showed a tendency to increase. The 
increase in percent body protein (Fig. 9) without significant 
change in total protein content reflects the significant 
decrease in total fat content. The increase in body O2 
consumption without the increase in total body protein 
suggests that the lean body mass or high protein-containing 
tissues increased oxidative activity in response to T3 
treatment. 
Contradictory reports exist about serum concentrations of 
T4 and T3 in ob/ob mice and whether the defects in metabolism 
reside in malfunction of pituitary-thyroid axis or 
insensitivity of extrathyroidal tissues to circulating 
hormones. The experiments reported here showed that ob/ob 
mice exhibit decreased serum T4 and T3 concentrations and that 
T3 treatment in the early stage of obesity corrected these 
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variables. These findings suggests that low serum T3 and T4 
are from insufficient production of these hormones in thyroid 
glands. Also, thyroid gland did not respond to increased 
serum TSH in ob/ob mice to produce more T4 and T3. Because 
serum T4 was much below the normal range (60-160 nmol/L) than 
was serum T3 (1.0-3.0 nmol/L) (Fig. 3), I believe that the 
deiodination of T4 to T3 in ob/ob mice is not totally 
defected. Also, T3 treatment increased body temperature, body 
oxygen consumption and decreased total body fat in the ob/ob 
mice. Because total body protein was not significantly 
changed, the increase in whole body metabolism after T3 
treatment is probably due to increased activity of the protein 
fractions or the most metabolically active tissues. 
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Footnotes 
^AIN mineral mix 76, ICN Biomedicals, Costa Mesa, CA. 
Composition of nutrients per kg mineral mixture; calcium 
phosphate dibasic, 500 g; sodium chloride, 74 g; potassium 
citrate monohydrate, 220 g; potassium sulfate, 52 g; magnesium 
oxide, 24 g; manganous carbonate (43-48% Mn), 3.5 g; ferric 
citrate (16-17% Fe), 6 g; zinc carbonate (70% ZnO), 1.6 g; 
cupric carbonate (53-55% Cu), 0.3 g; potassium iodate, 0.01 g; 
sodium selenite, 0.01 g; chromium potassium sulfate, 0.55 g; 
sucrose, finely powdered, 118 g. 
^AIN vitamin mix 76, ICN Biomedicals, Costa Mesa, CA. 
Composition of nutrients per kg vitamin mixture: Thiamine-HCl, 
600 mg; riboflavin, 600 mg; pyridoxine HCl, 700 mg; nicotinic 
acid, 3.0 g; D-calcium pantothenate, 1.6 g; folic acid, 200 
mg; D-biotin, 20 mg; cyanocobalamine, 1.0 mg; retinyl 
palmitate (250,000 lU/g), 1.6 g; DL-alpha-tocopherol acetate 
(250 lU/g), 20 g; cholecalciferol (400,000 lU/g), 250 mg; 
menaquinone, 5 mg; sucrose, finely powdered, 972.9 g. 
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PAPER II. EARLY TREATMENT OF OBESE (OB/OB) MICE WITH 
TRIIODOTHYRONINE INCREASES OXIDATIVE METABOLISM 
IN MUSCLE BUT NOT IN BROWN ADIPOSE AND LIVER 
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ABSTRACT 
Early defects in the ob/ob mouse are low body oxidative 
metabolism and low levels of circulating thyroid hormones. I 
explored the possibility that early T3 treatment may improve 
oxidative metabolism in metabolically important tissues such 
as muscle, white and brown adipose tissue, and liver in the 
ob/ob mice. T3, ranging from 0.0 to 25.0 fxg/lOO g BW, was 
injected intraperitoneally into ob/ob and non-ob/ob mice daily 
from 3 weeks until 6 weeks of age. Food intake was equalized 
across all groups to that consumed by the non-ob/ob saline-
treated group to remove the effects of hyperphagia. At 6 
weeks of age, the O2 consumption of the above tissues was 
measured. The saline-treated ob/ob mice showed lower muscle 
weights, higher fat pad and liver weights, and larger fat cell 
sizes than saline-treated non-ob/ob mice. In ob/ob mice, 
tissue O2 consumption was lower in muscle and brown and white 
adipose tissue but higher in liver as compared with that in 
same tissue of saline-treated non-ob/ob mice. Early T3 
treatment in ob/ob mice during growth resulted in 
significantly lower values for body weight, liver weight, 
hepatocyte number, liver protein, epididymal fat pad weight, 
and white adipocyte number and size than those values in 
saline-treated ob/ob mice. T3 treatment increased muscle. 
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liver and brown adipose tissue O2 consumption in non-ob/ob 
mice. In ob/ob mice, T3 only increased muscle Og consumption 
and required higher doses than in non-ob/ob mice to achieve a 
change. These data are consistent with the concept of tissue 
T3 resistance in ob/ob mice. Low T3 levels and tissue 
resistance to T3 seem to be important early defects in this 
obesity syndrome. 
Key words triiodothyronine, oxidative metabolism, muscle, 
liver, white adipose tissue, brown adipose tissue 
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INTRODUCTION 
The genetically hyperglycemic obese (ob/ob) mouse is 
extensively used for the study of human obesity. Major 
characteristics of ob/ob mouse are low oxygen consumption and 
low body temperature, which can be detected at 2 weeks of age 
and before the obesity is phenotypically expressed (Kaplan and 
Leveille 1974). These mice show decreased thermogenic 
activity of brown adipose tissue as measured by GDP binding to 
mitochondria, which was also detectable early and when obesity 
was not apparent (Goodbody and Trayhurn 1982, Himms-Hagen and 
Desautels 1978). Oxygen consumption of brown adipose tissue 
was lower in ob/ob than in non-ob/ob mice (Thurlby and 
Trayhurn 1980). Thyroid hormones potentiate the 
norepinephrine-stimulated GDP binding to brown adipose tissue 
mitochondria. This thermogenic activity is reduced in the 
brown adipose tissue of ob/ob mice (Himms-Hagen 1983a, Hogan 
and Himms-Hagen 1981). 
Thyroid hormones are lower in ob/ob mice than in non-ob/ob 
mice during thermal stress (Bray and York 1971, Joosten and 
Van der Kroon 1974). The defects in thermogenesis in ob/ob 
mice may be attributed to impaired thyroid hormone action. 
Supportive of this concept are reports that the thyroid 
hormone-sensitive Na*-K*-ATPase is lower in the liver and 
skeletal muscle of ob/ob mice than of non-ob/ob mice (Lin et 
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al. 1979, York et al. 1978a). Recently, Hillgartner and 
Romsos (1988) reported that the ob/ob mice had lower hepatic 
thyroid hormone uptake than did non-ob/ob mice. This may 
account for the impaired thyroid hormone action and T3 
production in the liver, which is the major site for T3 
production from T4. 
Thyroid hormones are known to increase metabolic rate. 
Previously, I reported that T3 treatment increased oxygen 
consumption and both non-insulin-stimulated and insulin-
stimulated glucose utilization in ob/ob mice, and eliminated 
the insulin resistance by skeletal muscle (Oh and Kaplan 
1989). Others have also shown that T3 treatment increased 
anaerobic glycolysis in muscle (Nicole and Johnston 1981). 
Skeletal muscle plays a major role in glucose utilization 
(DeFronzo et al. 1981, Katz et al. 1983). Significant amounts 
of energy are also used by the skeletal musculature (Martin 
and Fuhrman 1955). Because O2 consumption is lower in some 
muscles of ob/ob mice (Conway and Kaplan 1977, Kaplan and Oh 
1991), the role of T3 treatment of ob/ob mice on muscle O2 
consumption was further explored. 
Thyroid hormones are also known to increase fatty acid 
mobilization from adipose tissue in rat (Fain and Rosenthal 
1971). In ob/ob mice, the impaired norepinephrine-stimulated 
lipolysis was increased by exogenous thyroid hormone (Otto et 
al. 1976, Thenen and Carr 1978), but York et al. (1978b) 
61 
reported that adipose tissue lipolysis of ob/ob mice was less 
sensitive to thyroid hormone than that of non-ob/ob mice. In 
preadipocyte cell lines from both ob/ob and non-ob/ob mice, T3 
increased both fatty acid synthesis and lipolysis (Pou and 
Torresani 1989). Thyroid hormones stimulated hepatic fatty 
acid synthesis and esterification in the rat (Diamant et al. 
1972, Mariash et al. 1980). Also, T3 treatment increased O2 
consumption in isolated perfused liver (Horst et al. 1989, 
Millier and Seitz 1980) and in isolated hepatocytes (Gregory 
and Berry 1991). Liver utilized 30-40 % of the resting oxygen 
consumption (Martin and Fuhrman 1955) and therefore should be 
explored as a possible site for the increased total O2 
consumption in response to T3 treatment. 
The metabolic responses to thyroid hormones are different 
in many tissues (Barker and Klitgaard 1952, Schwartz 1983). 
T3 treatment increased whole body oxygen consumption in ob/ob 
mice (Oh and Kaplan 1989). Major metabolically important 
tissues should account for the change in whole body 
metabolism. Although a controversy exists about the role of 
brown adipose tissue in human obesity, it is a thermogenically 
important tissue in ob/ob mice (Hogan and Himms-Hagen 1981). 
White adipose tissue is important in energy balance and should 
also be explored in terms of oxidative metabolism. The 
present report explores the possibility that early T3 
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treatment of ob/ob mice over a 3-week period will alter the 
energy expenditure of major metabolically active tissues. 
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MATERIALS AND METHODS 
Animals and Diets. Male obese (C57BL/6J-ob/ob) mice and 
their nonobese (non-ob/ob) littermates were obtained at 2 
weeks of age from the animal colony of the Food Science and 
Human Nutrition department of Iowa State University. At 2 
days of age, litter size was adjusted to 7-9 mice per litter 
to allow pups to even access to nurturing female mouse. 
Oxygen consumption was measured at 16 days of age on the basis 
of the low oxygen consumption exhibited by future obese mice 
(Kaplan and Leveille 1974). In this study, 2000 jLtl O^/hr g 
body weight at STP was used as the value below which 2-week-
old mouse pups are identified as obese with 99.9% reliability 
(the average value of O2 consumption is 2322.0 for non-ob/ob 
and 1439.9 /Ltl/hr-g BW for ob/ob mice). All mice were housed 
individually in solid bottom plastic cages with aspen wood 
shavings for bedding in an animal room at 23 ± l=C with a 12-
hour dark-light cycle (dark cycle 0600-1800 hr, light cycle 
1800-0600 hr). All mice were fed a high carbohydrate diet 
during the 6-hour feeding period from 1000 to 1600 hr and 
allowed free access to tap water. The diet consisted of: 
casein, 20.0 g; DL-methionine, 0.3 g; AIN mineral mix 76^, 3.5 
g; AIN vitamin mix 7 6^, 1.0 g; choline chloride, 0.2 g; corn 
oil, 5.0 g; fiber, 5.0 g; dextrose, 60.0 g; and dextrin, 5.0 g 
per 100 g diet. The diet was pelleted to facilitate the 
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measurement of food consumption. Food intake was equalized 
daily across all groups to the average consumed by non-ob/ob 
saline-treated group on the previous day. Food consumption 
and body weight were measured daily until 6 weeks of age. 
Mice were treated with L-triiodothyronine(T3) as indicated 
below. 
Treatments. Obese and nonobese mice were divided into 7 
groups. Six levels of 2.5, 5.0, 7.5, 10.0, 12.5, and 25.0 ng 
L-T3/IOO g BW, dissolved in 0.154M NaCl (saline) (final pH 9.1 
to keep the T3 soluble), were injected intraperitoneally 
daily, between 0900 and 1000 hr from 3 to 6 weeks of age. 
Untreated ob/ob and non-ob/ob mice were injected with saline, 
pH 9.1. Body weight was measured daily at the time of the 
treatment. At 6 weeks of age, mice were killed by 
decapitation and skeletal muscle, adipose, or liver tissues 
were dissected and processed as described below. 
Muscle oxygen consumption. The soleus muscles were 
dissected and stretched on pre-weighed horse-shoe shaped 
stainless steel wire clips. The muscles were then weighed and 
placed into 25 ml polycarbonate incubation flasks that 
contained 3 ml of incubation media, consisting of 5 mM 
glucose, 0 or 1000 /itU/ml insulin in Krebs-Ringer bicarbonate 
(KRB) buffer (DeLuca 1964), pH 7.4, with one half the 
recommended calcium level to bring calcium to a physiological 
level (1.22% CaCl2'2H20), and gassed with 95% O2, 5% CO2 at 
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37°C in a gyrotory metabolic shaker. The diaphragm muscles 
were also dissected with ribs attached. After adipose tissue 
and other unwanted muscles and blood vessels were trimmed, the 
diaphragm was cut in half and rinsed in 0.9% saline. The 
hemidiaphragms were placed into incubation flasks with the 
same conditions as the soleus muscles. After 30 min of 
incubation, the diaphragms were dissected from the ribs. 
Then, soleus and diaphragm muscles were transferred to the O2 
electrode chamber, which contained the same media, and the 
chamber was gassed to saturation with 95% O2, 5% CO2. The 
chambers were sealed, bubbles were carefully removed, and the 
injection ports were sealed with mineral oil to minimize the 
leakage of O2. Oxygen content of the media was determined by 
the method of Robinson and Cooper (1970). Oxygen consumed by 
muscle tissue in the chamber was recorded by YSI multi-channel 
biological oxygen monitor (Yellow Springs Instrument Co., 
Yellow Springs, OH) for 10 min. 
Muscle protein assay. Each muscle sample was homogenized 
in 1 ml of H2O. The homogenates were analyzed for protein 
content by the biuret method (Layne, 1957) with bovine serum 
albumin (BSA) as the protein standard. 
Adipocytes isolation. Epididymal adipose tissue and 
interscapular brown adipose tissue were dissected and weighed. 
Fat pads were rinsed in 0.9% saline and snips of both white 
and brown fat pads were fixed with 3% OSO4 in 50 mM collidine 
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(2,4,6-triinethylpyridine) buffer, pH 7.4 (Hirsch and Gallian 
1968) for later determination of cell number and size. The 
white adipocytes were isolated by the method of Rodbell 
(1964). For epididymal fat pads, the remnants of the fat pads 
were placed into 25 ml polypropylene flask which contained 3 
ml of KRB, 3% BSA, 0.1% type IV collagenase, pH 7.4 at 37°C. 
The tissues then minced with scissors into smaller pieces. 
The flasks were placed in a gyrotory metabolic shaker at 37°C 
and gassed with 95% O2, 5% CO2 for one hour. After the 
incubation, the digestion mixture was filtered through a 250-
jum nylon screen (Tetko Co.) and rinsed with KRB-3% BSA twice. 
Then, the filtrate was resuspended in KRB-3% BSA, pH 7.4, 
centrifuged at 150 x g for 1 min and rinsed twice with KRB, 3% 
BSA. After final centrifugation, the white adipocytes were 
suspended in KRB, 1% BSA, pH 7.4. Rough estimation of cell 
count was determined in a Fuchs-Rosenthal counting chamber 
(0.2 mm deep) microscopically by suspension in 0.3% trypan 
blue, 0.9% NaCl. Cells were generally 90% viable as 
determined by exclusion of the dye. A 0.2 ml of each cell 
suspension was fixed in 3% OSO4 in 50 mM collidine buffer, pH 
7.4, to obtain a precise cell count at a later date. 
For brown adipocytes, cells were isolated in the same 
manner except that concentration of type IV collagenase was 
increased to 0.2% in KRB as recommended by Fain (1975). 
During incubation, the flasks with minced brown fat pads were 
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removed from the shaker and shaken by hand every 10 min for 
10-15 sec to accelerate cell isolation. Viability of brown 
adipocytes was determined as in white adipocytes except that 
brown adipocytes were counted in Lange-Levy chamber (0.1 mm 
deep). 
Adipocytes oxygen consumption. The volume of isolated cell 
suspension was adjusted to have approximately 0.5 x 10® 
cells/ml. Each 1 ml of diluted fresh cell suspension was 
added to tubes which contained 2 ml of one of the following: 
no substrate, 5 mM glucose, 2 mM pyruvate, 1 mM palmitate, or 
2 mM acetate in KRB buffer with 1% BSA, pH 7.4. These tubes 
with cells and substrates were incubated at 37°C for 15 min in 
a gyrotory metabolic shaker and gassed with 95% O2, 5% CO2. 
After incubation, 2 ml of each cell suspension with substrate 
were placed into O2 electrode chamber and gassed to saturation 
with 95% 02/ 5% CO2. The chambers were sealed, and mineral 
oil was injected into the injection ports. Oxygen consumption 
of adipocytes was recorded for 10 min with a YSI oxygen 
monitor. Oxygen content of each medium was determined by the 
method of Robinson and Cooper (1970). 
Adipose tissue and cell fixation for determination of cell 
number and size. Fixed cells were counted (Hirsch and Gallian 
1968) with a Coulter counter, model Zg, (Coulter Electronics 
Inc., Hialeah, FL) and sized in 10 categories of cell diameter 
as previously described (Kaplan et al. 1980). The average 
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cell size was also calculated for each sample as a grouped 
mean from the frequency distribution. 
Hepatocyte isolation. The liver was dissected with the 
portal vein intact, rinsed in cold 0.9% saline, blotted, and 
weighed. A snip of liver was saved and frozen for later 
determination of protein. Hepatocytes were isolated by a 
modification of the method of Howard et al. (1973). The liver 
was perfused at 10 ml/min via the portal vein with cold 
calcium-free KRB buffer, pH 7.4, which contained 20 mM HEPES, 
5 mM glucose, 1 mM pyruvate, 0.05% type II collagenase, 0.1% 
hyaluronidase, 95% O2, 5% CO2, for 5 min. The perfusate was 
not recirculated, and the reservoir of perfusate was 
continuously gassed with 95% O2, 5% CO2. Removal of blood 
from the liver was noted by blanching of all the lobes within 
2 min. The liver was minced with a scalpel and placed into a 
25 ml polycarbonate flask which contained 5 ml of the same 
media as the perfusate and incubated at 37°C in a metabolic 
shaker for 30 min, and under 95% O2, 5% CO2. After 30 min, 
0.05 ml of 1.86% CaCl2'2H20 was added, and incubation was 
continued for another 3 0 min. The filtrate with cells were 
collected by filtering through a 100 /xm nylon screen and 
rinsed with complete KRB (KRB with calcium), 20 mM HEPES, 1% 
BSA, 95% O2, 5% CO2, pH 7.4. The cell suspension was 
centrifuged at 120 x g for 1 minute. The hepatocytes were 
resuspended in complete KRB, 20 mM HEPES, 1% BSA, pH 7.4, and 
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centrifuged at 50 x g for 2 min. This resuspension-
centrifugation repeated twice to rinse out enzymes. The final 
pellet was suspended in the same media. The cells were 
counted in a Lange-Levy hemocytometer chamber (0.1 mm deep) 
and the viability was determined by exclusion of 0.6% trypan 
blue. One ml of cell suspension was saved for later protein 
determination. 
Hepatocyte oxygen consumption. Oxygen consumption of 
isolated hepatocytes was measured with a Clark-type oxygen 
electrode as described for the adipocyte O2 consumption 
method. 
Hepatocyte protein assay. The protein contents in the 
liver snip and an aliquot of the cell suspension were 
determined by the method of Lowry et al. (1951) . I assumed 
the liver cells accounted for almost all protein in the liver. 
Chemicals. L-3,3',5-Triiodothyronine was purchased from 
Calbiochem-Behring Co. (La Jolla, CA). Dextrose (anhydrous, 
granular) was purchased from Mallinckrodt Chemical Works (New 
York, NY). Porcine insulin and bovine serum albumin (RIA 
grade) were purchased from Sigma Chemical Co. (St. Louis, MO). 
A gyrotory water bath shaker (model 76) was purchased from New 
Brunswick Scientific (Edison, NJ). Collidine (2,4,6-
trimethylpyridine) was purchased from Aldrich (Milwaukee, WI). 
Osmium tetroxide (OSO4) was purchased from Electron Microscopy 
Sciences (Fort Washington, PA). Collagenases (type II and 
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type IV) and hyaluronidase were purchased from Worthington 
Biochemical Co. (Freehold, NJ). Nylon screens were purchased 
from Tetko Co. (Elmsford, NY). Folin-Ciocalteau reagent was 
purchased from Sigma Chemical Co. (St. Louis, MO). All other 
reagents were purchased from Fisher Scientific Co. (Fair Lawn, 
NJ) . Diet ingredients were purchased from ICN Biomedicals 
(Costa Mesa, CA). 
Statistics. Overall statistical significance was 
determined by analysis of variance (Ray 1982, Snedecor and 
Cochran, 1980). Main effects include T3 treatment and 
phenotype. Significant main effects and interactions were 
identified and means within these main effects were tested 
with the protected t-test which uses the mean square of the 
error term from the ANOVA. Adipocyte size distribution was 
analyzed by multivariate analysis of variance (MANOVA), and 
using proportions weighted for the number of cells counted in 
each sample. The Wilks' Lambda test after conducting the 
ANOVA (GLM) was used to determine the discriminatory power of 
the model (SAS Institute Inc. 1985). 
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RESULTS 
Body weight and food consumption. At 6 weeks of age, no 
significant differences in body weight between ob/ob and non-
ob/ob mice in saline-treated groups were observed in three 
different sets of experiments (Table 1, 2, 3). T3 treatment 
significantly decreased body weight in both phenotypes. Total 
food consumption during the experimental period was similar in 
both phenotypes because food was equalized across all ob/ob 
and non-ob/ob groups throughout this period. The average 
total food intake during the T3 treatment period for all 
groups was 47 g/mouse 3 weeks. The average weekly food 
consumption in all groups in the first set of experiment was 
8.3 g (4 weeks), 17.1 g (5 weeks), and 21.7 g (6 weeks). The 
second and third sets of experiments followed the same trend. 
Because food consumption was equalized across all groups, no 
significant differences were found in total food consumed by 
all groups in these series of experiments. 
Muscle weight and muscle protein. In saline-treated ob/ob 
mice, both soleus and diaphragm muscle weights were 
significantly lower than those of saline-treated non-ob/ob 
mice (Table 1). Overall, T3 treatment did not change soleus 
muscle weight in either phenotype. In diaphragm muscles, T3 
treatment decreased the dissectable muscle weight in non-ob/ob 
but not in ob/ob mice. No differences in total soleus muscle 
TABLE 1 
Muscle weight and total muscle protein in T3 treated ob/ob and non-ob/ob mice^ 
T3 Body wt. Soleus muscle Hemidiaphragm muscle 
(/ig/100 g BW) (g) wt. (mg) protein (mg) wt. (mg) protein (mg) 
0.0 non-ob/ob 19.4 (18) 9.1 (50) 1.71 50) 13.4 (50) 2.59 50) 
ob/ob 19.2 (8) 7.7 (32) + 1.36 32) 10.8 (32) + 2.24 32) 
2.5 non-ob/ob 18.8 (8) 8.9 (16) . 1.50 16)* 12.6 (16) 2.35 16) 
ob/ob 17.8 (7) 7.3 (14) + 2.07 14)* 11.1 (14), 2.45 14) 
5.0 non-ob/ob 18.5 ( 9 )  8.0 (18) 1.52 18) 11.3 (18) 2.34 18) 
ob/ob 17.8 (8). 7.7 (16) 1.51 15) 10.6 (16), 2.51 16) 
7.5 non-ob/ob 17.9 (9) 9.0 (18)^ 2.02 18) 11.5 (18)* 2.67 18) 
ob/ob 18.0 (6) 7.0 (14) + 1.50 14) 10.7 (14) 2.87 14) 
10.0 non-ob/ob 18.3 ( 9 ) *  9.3 (18) 2.05 17) 13.4 (18) . 2.74 18) 
ob/ob 16.9 (8)* 6.7 (16) + 1.42 16) 11.0 (16) + 2.30 16) 
12.5 non-ob/ob 17.9 (9)* 8.8 (17) 1.70 17) 13.8 (18)^ 2.91 18) 
ob/ob 17.6 (8), 7.6 (16) 1.29 16)* 11.1 (16) + 2.80 16), 
25.0 non-ob/ob 17.6 (8)* 8.9 (18) . 0.85 18) 11.4 (18)* 1.73 18) 
ob/ob 16.2 (6)* 6.6 (12) + 0.82 12) 9.9 (12) 1.93 12) 
ANOVA (GLM) 
Phenotype MS 0. 0001 NS 0. 0001 NS 
T 3  NS NS 0.0102 0. 0235 0.0045 
Phenotype x T3 MS NS NS NS NS 
MSE^ 3.9706 2. 8760 1.1074 6. 7850 1.0518 
^Values are the means of the number of samples in the parentheses. The mice were treated 
with T3 from 3 to 6 weeks of age as outlined in Materials and Methods. ^MSE = Mean square of 
the error term from the ANOVA and is used in the protected t-test to determine significant 
differences between means. *Significantly different from the corresponding 0.0 /ig T3/IOO g BW 
at P < 0.05 level, ^Significantly different from non-ob/ob littermates at P < 0.05 level. 
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protein and total diaphragm muscle protein contents were found 
in saline-treated ob/ob and non-ob/ob mice (Table 1). In 
general, T3 treatment did not change total soleus muscle 
protein in both phenotypes, except in ob/ob mice at 2.5 fig T3 
level that increased protein content. Total diaphragm muscle 
protein in both phenotypes did not change with T3 treatment. 
Liver weighty total hepatocyte number, and total liver 
protein. The weight of liver from saline-treated ob/ob mice 
and their relative liver weight (% liver wt./body wt.) were 
significantly higher than those of saline-treated non-ob/ob 
mice (Table 2). All levels of T3 treatment significantly 
decreased ob/ob liver weight and relative liver weight, and 
phenotypic differences were no longer present after the 
treatment. T3 treatment did not significantly change liver 
weight and relative liver weight in non-ob/ob mice. Total 
number of hepatocytes was not significantly different between 
saline-treated ob/ob and non-ob/ob mice (Table 2). T3 
treatment significantly decreased the total number of 
hepatocytes in both phenotypes. Total liver protein was 
significantly higher in saline-treated ob/ob mice than in 
saline-treated non-ob/ob mice (Table 2). T3 treatment 
significantly decreased total liver protein in both 
phenotypes, and the differences between ob/ob and non-ob/ob 
mice were no longer obvious. 
TABLE 2 
Liver weighty total hepatocytes, and total liver protein in treated ob/ob and non-
ob/ob mice^ 
T3 Body wt. Liver wt. Liver wt. Hepatocytes Protein 
(/ig/100 g BW) (g) (g) (% of BW) (xlO® cells) (mg/liver) 
0.0 non-ob/ob 22. 3 18) 0.97 (18) 4.36 18)^ 4.808 18) 206.8 (18)^ 
ob/ob 22. 6 18)* 1.15 (18) + 5.10 18) + 6.203 18) 239.0 (18) 
2.5 non-ob/ob 20. 5 18)* 0.95 (18). 4.73 18)* 5.857 18) 194.2 (18)* 
ob/ob 20. 3 18) ; 0.95 (18)* 4.69 IB)* 4.411 18)* 206.0 (18) 
5.0 non-ob/ob 20. 5 18)* 0.90 (18)* 4.40 18) 2.486 18)* 195.3 (18)* 
ob/ob 20. 2 18)* 0.97 (18) 4.85 18)* 4.433 18) 210.1 (18) 
12.5 non-ob/ob 20. 0 18)* 0.95 (18)* 4.80 18)* 2.956 18) 193.0 (18)* 
ob/ob 19. 6 18)* 0.95 (18)* 4.82 18) 3.495 18)* 198.0 (18)* 
25.0 non-ob/ob 19. 4 18)* 0.90 (18)* 4.67 18) 2.012 18)* 178.8 (18)* 
ob/ob 19. 1 18) * 0.92 (18) 4.83 18) 3.635 18) 190.2 (18) * 
ANOVA (GLM) 
Phenotype NS 0.0047 0.0015 NS 0.0046 
T3 0. 0001 0.0001 NS 0.0147 0.0002 
Phenotype x T3 NS 0.0095 0.0166 NS NS 
MSE^ 7. 04083 0.01517 0.30482 16.5764 1237. 89 
^Values are the means of the number of samples in the parentheses. The mice were treated 
with T3 from 3 to 6 weeks of age as outlined in Materials and Methods. MSB = Mean square of 
the error term from the ANOVA and is used in the protected t-test to determine significant 
differences between means. *Significantly different from the corresponding 0.0 ng T3/IOO g BW 
at P < 0.05 level, """significantly different from non-ob/ob littermate at P < 0.05 level. 
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Epididymal and brown adipose tissue weight, cell number, 
and size. Epididymal fat pad weight in saline-treated ob/ob 
mice was significantly higher than that of saline-treated non-
ob/ob mice (Table 3). T3 treatment significantly decreased 
epididymal fat pad weight at all doses of T3 in ob/ob mice and 
at higher doses in non-ob/ob mice. However, ob/ob epididymal 
fat pads always weighed more than non-ob/ob fat pads. The 
total number of epididymal adipocytes was higher in saline-
treated non-ob/ob than in saline-treated ob/ob mice (Table 3). 
T3 treatment decreased the number of epididymal adipocytes in 
both non-ob/ob and ob/ob mice. After T3 treatment, phenotypic 
differences in total number of epididymal adipocytes per fat 
pad pair were no longer apparent. 
Dissectable interscapular brown fat pads weights were 
higher in all groups of ob/ob mice than in corresponding non-
ob/ob mice (Table 3). T3 treatment increased non-ob/ob brown 
fat pad weight at higher doses but did not affect ob/ob brown 
fat pad weight. In brown adipose tissues, no differences in 
total number of brown adipocytes existed between saline-
treated ob/ob and non-ob/ob mice (Table 3). T3 treatment 
increased only the number of non-ob/ob brown adipocytes. The 
number of brown adipocytes did not change in ob/ob mice with 
T3 treatment. 
The size distribution of epididymal adipocytes in saline-
treated ob/ob mice was significantly different from that of 
TABLE 3 
Adipose tissue weight, cell number and average cell size in T3 treated ob/ob and non-
ob/ob mice^ 
(Mg/100 g BW) 
Body wt. (g) Epididymal fat pad wt.(g) cell no.(xlO ) wt.(g) Brown fat pad cell no.(xlO°) 
0. 0 non-ob/ob 22. 1 (20) 0. 396 (20) 1. 664 (20) 0. 122 (20) 3 .473 (20) 
ob/ob 23. 4 (20) 0. 804 (20) + 1. 315 (20) + 0. 289 (20) + 3 .539 (20) 
2. 5 non-ob/ob 21. 2 (20) 0. 316 1. 338 (20)* 0. 169 (20) 4 .535 (20) 
ob/ob 21. 1 (20)* 0. 631 1. 067 (20) 0. 303 (20) + 3 .331 (20) 
5. 0 non-ob/ob 21. 3 (20) 0. 308 
!-îr 
1. 405 (20) 0. 161 (20) 4 .656 (20) 
ob/ob 20. 9 (20)* 0. 599 1. 159 (20) 0. 295 (20) + 3 .556 (20) 
12. 5 non-ob/ob 20. 1 (20)* 0. 267 1. 565 (20) 0. 188 (20)* 5 -649 (20)* 
ob/ob 20. 4 (20)* 0. 553 1. 254 (20) 0. 312 (20) + 3 .112 (20) + 
25. 0 non-ob/ob 20. 5 (20)* 0. 254 1. 009 (20)* 0. 200 (20)* 3 .715 (20) 
ob/ob 20. 1 (20)* 0. 521 1. 064 (20) 0. 332 (20) + 3 .796 (20) 
-J 
m 
Phenotype NS 
T] 0.0001 
Phenotype x T3 NS 
ANOVA (GLM) 
0.0001 0.0015 
0.0001 0.0005 
NS NS 
0.0001 
0.0301 
NS 
0.0041 
NS 
NS 
MSE< 5.27 0.0201 0.00885 0.249 5.165 
^Values are the means of the number of samples in the parentheses. The mice were treated 
with T3 from 3 to 6 weeks of age as outlined in Materials and Methods. MSB = Mean square of 
the error term from the ANOVA and is used in protected t-test to determine significant 
differences between means. *Significantly different from corresponding 0.0 /xg T3/IOO g BW at P 
< 0.05 level, ^significantly different from non-ob/ob littermate at P < 0.05 level. 
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non-ob/ob mice (Fig. 1). Saline-treated non-ob/ob mice showed 
higher proportions of adipocytes in the 40-63 fxm diameter 
range, and saline-treated ob/ob mice had higher proportions in 
63-100 fxm range. Unlike non-ob/ob adipocytes, ob/ob 
adipocytes exhibited a bimodal distribution in all treatment 
groups with high proportions of both small cells and large 
cells, which is not reflected by average cell size. T3 
treatment resulted in the increase in the proportion of 
smaller adipocytes and the decrease in the proportion of 
larger cells in the ob/ob mice. The peak of the distribution 
in ob/ob mice shifted to the smaller diameter categories but 
still had higher proportions in the larger cell categories 
than in non-ob/ob mice. 
The brown adipocyte size distribution in ob/ob mice did not 
exhibit a bimodal distribution (Fig. 2). Saline-treated ob/ob 
and non-ob/ob mice showed similar distribution patterns, 
having high proportions of 10-16 /xm diameter cells. However, 
ob/ob mice had more cells in the ranges of 25-40 /xm than did 
non-ob/ob which had higher proportions in the 16-25 jum ranges. 
T3 treatment shifted the distribution in non-ob/ob mice 
towards the ranges of 20-32 urn. In the ob/ob mice, T3 
treatment minimally shift the proportions towards the ranges 
of 10-25 /im. 
The average cell sizes were generated from the frequency 
distributions for each sample in Fig. 1 and 2. The average 
Figure 1 Frequency of adipocyte size distribution in 
epididymal fat pads from T3 treated ob/ob and non-ob/ob mice 
at 6 weeks of age. The mice were treated with T3 from 3 to 6 
weeks of age as outlined in Materials and Methods. Values are 
the means for 20 mice per group. A through J refers to the 
diameter of cells in ten size categories; A = 25-32 /xm, B = 
32-40 urn, C = 40-50 fim, D = 50-63 E = 63-80 /J,m, F = 80-100 
urn, G = 100-127 fim, H = 127-159 /xm, I = 159-200 fixa, J = 200-
253 fim. The Wilks' lambda test was used after conducting 
MANOVA to test significant main effect and interaction. The 
MANOVA showed significant T3 effect at P < 0.0001, phenotype 
effect at P < 0.0001, and T3 x phenotype effect at P < 0.0001. 
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Figure 2 Frequency of adipocyte size distribution in brown 
fat pads from T3 treated ob/ob and non-ob/ob mice at 6 weeks 
of age. The mice were treated with T3 from 3 to 6 weeks of 
age as outlined in Materials and Methods. Values are the 
means for 20 mice per group. A through L refers to the 
diameter of cells in twelve size categories; A = 10-16 fira, B = 
16-20 urn, C = 20-25 )Ltm, D = 25-32 (im, E = 32-36 fim, F = 36-40 
jlim, G = 40-45 fixa, H = 45-50 /xm, I = 50-63 /xm, J = 63-71 /xm, K 
= 71-80 jum, L = 80-100 nm. The Wilks' lambda test was used 
after conducting MANOVA to test significant main effect and 
interaction. The MANOVA showed significant T3 effect at P < 
0.0001, phenotype effect at P < 0.0001, and T3 x phenotype 
effect at P < 0.0001. 
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cell size of epididymal adipocytes in saline-treated ob/ob 
mice was significantly larger than in saline-treated non-ob/ob 
(Table 4). T3 treatment decreased the average size of 
epididymal adipocytes in both phenotypes at all doses of T3. 
However, ob/ob mice always had larger cell sizes than did 
those of non-ob/ob mice. The average size of brown adipocytes 
in ob/ob mice was larger than non-ob/ob in all groups. T3 
treatment increased the average cell size of brown adipocytes 
in non-ob/ob mice, and not in ob/ob mice. 
Muscle oxygen consumption. In ob/ob soleus muscles, O2 
consumption in saline-treated group was significantly lower 
than that of non-ob/ob mice. T3 treatment increased both non-
insulin-stimulated and insulin-stimulated O2 consumption at 
7.5 nq/100 g BW and higher levels of T3 (Fig. 3). Also, T3 
treatment increased insulin sensitivity of soleus muscle O2 
consumption in non-ob/ob mice. 
In non-ob/ob diaphragm muscles, T3 treatment increased non-
insulin-stimulated O2 consumption at 2.5 /xg/lOO g BW T3 level, 
maintained those levels of O2 consumption, and also increased 
insulin-stimulated O2 consumption (Fig. 3). Diaphragm muscles 
in saline-treated ob/ob mice were not sensitive to exogenous 
insulin, and insulin-stimulated O2 consumption was 
significantly lower than that in muscles in non-ob/ob mice. 
T3 treatment increased the sensitivity of ob/ob diaphragm to 
TABLE 4 
Average cell size^ 
T3 {ng/100 g BW) Epididymal adipocytes (fim) Brown adipocytes (urn) 
non-ob/on ob/ob non-ob/ob ob/ob 
0. 0 54 . 95 (20) 70. 03 (20) < 0.0001 19.28 (20) 26.67 (20) < 0.0001 
2. 5 52. 94 (20) 66. 26 (20)* < 0.0001 19.87 (20) 25.43 (20) < 0.0001 
5. 0 50. 74 (20)* 63 . 44 (20)* < 0.0001 21.38 (20)* 25.88 (20) < 0.0001 
12. 5 49. 67 (20)* 64. 87 (20)* < 0.0001 21.83 (20)* 25.37 (20) < 0.0001 
25. 0 49. 85 (20)* 60. 75 (20)* < 0.0001 22.18 (20)* 25.39 (20) < 0.0001 
Phenotype 
T3 
Phenotype x T3 
0.0001 
0.0001 
NS 
ANOVA (GLM) 
0.0001 
NS 
0.0018 
MSB'' 34. 18 6.621 
^Values are the means of the number of samples in the parentheses. The mice were treated 
with T3 from 3 to 6 weeks of age as outlined in Materials and Methods. ^HSE = Mean square of 
the error term from the ANOVA and is used in the protected t-test to determine significant 
differences between means. *Significantly different from the 0.0 fig T3/IOO g BW within 
phenotypes at P < 0.05 level. 
Figure 3 Soleus and diaphragm muscles oxygen consumption 
per unit muscle protein in T3 treated ob/ob and non-ob/ob mice 
at 6 weeks of age. The mice were treated with T3 from 3 to 6 
weeks of age as outlined in Materials and Methods. Values are 
the means ± SEM for 8-9 mice per group. For soleus muscle, 
the ANOVA showed a significant insulin effect at P < 0.05. 
Mean square error is 12.180. For diaphragm, the ANOVA showed 
a significant insulin effect at P < 0.005. Mean square error 
is 1.9845. Significant differences between means were 
determined by using the protected t-test. *significantly 
different from the corresponding 0.0 nq T3/IOO g BW at P < 
0.05, ^significantly different from non-ob/ob at P < 0.05, 
^significantly different from non-insulin tissue at P < 0.05. 
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insulin and also increased both non-insulin-stimulated and 
insulin-stimulated O2 consumption. 
Hepatocyte oxygen consumption. In saline-treated ob/ob and 
non-ob/ob mice, no differences in hepatocyte O2 consumption 
per 10® cells were observed (Fig. 4). T3 treatment 
significantly increased hepatocyte O2 consumption per 10® 
cells in both phenotypes, but to a greater extent in the non-
ob/ob mice. Pyruvate showed the greatest substrate-induced 
respiratory rate, particularly after T3 treatment. The other 
substrates did not exhibit substrate-stimulated respiration 
after T3 treatment of the mice. When the data were expressed 
on a whole liver basis, the ob/ob mice had a higher O2 
consumption than did non-ob/ob mice in the saline-treated 
groups. T3 treatment significantly decreased whole liver O2 
consumption in both phenotypes (Fig. 4), and differences 
between phenotypes disappeared. The pyruvate-induced 
respiration was still higher after T3 treatment. 
Epididymal and brown adipocytes oxygen consumption. Oxygen 
consumption of saline-treated ob/ob epididymal adipocytes was 
lower than that of non-ob/ob mice on both a per cell basis and 
a per whole fat pad basis (Fig. 5). T3 treatment increased O2 
consumption in both phenotypes, although this difference was 
not statistically significant (P > 0.05). Epididymal 
adipocyte O2 consumption was lower in the ob/ob than that in 
non-ob/ob at all doses of T3. Pyruvate exhibited the highest 
Figure 4 Hepatocytes oxygen consumption per 10® cells and 
per liver in T3 treated ob/ob and non-ob/ob mice at 6 weeks of 
age. The mice were treated with T3 from 3 to 6 weeks of age 
as outlined in Materials and Methods. Values are the means ± 
SEM for 9 mice per group. For O2 consumption per 10® cells, 
the ANOVA showed significant T3 effect at P < 0.0001, 
phenotype effect at P < 0.0001, T3 x phenotype effect at P < 
0.0031 and substrate effect at P < 0.0001. Mean square error 
is 15100.778. For O2 consumption per liver, the ANOVA showed 
significant T3 effect at P < 0.0001, phenotype effect at P < 
0.0083, T3 X phenotype effect at P < 0.0001 and substrate 
effect at P < 0.0001. Mean square error is 27930.16. 
Significant differences between means were determined by using 
the protected t-test. *significantly different from the 
corresponding 0.0 ng T3/IOO g BW at P < 0.05, "''significantly 
different from non-ob/ob at P < 0.05, ^significantly different 
from KRB at P < 0.05. 
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Figure 5 Epididymal adipocytes oxygen consumption per 10® 
cells and per epididymal fat pad pair in T3 treated ob/ob and 
non-ob/ob mice at 6 weeks of age. The mice were treated with 
T3 from 3 to 6 weeks of age as outlined in Materials and 
Methods. Values are the means ± SEM for 10 mice per group. 
For O2 consumption per 10® cells, the ANOVA showed significant 
T3 effect at P < 0.0008, phenotype effect at P < 0.0001, and 
substrate effect at P < 0.0001. Mean square error is 0.1191. 
For O2 consumption per fat pad pair, the ANOVA showed 
significant T3 effect at P < 0.0001, phenotype effect at P < 
0.0001, and substrate effect at P < 0.0001. Mean square error 
is 0.2243. Significant differences between means were 
determined by using the protected t-test. "^significantly 
different from non-ob/ob at P < 0.05. 
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substrate Induced O2 consumption in comparison to other 
substrates in both phenotypes. 
Brown adipocyte oxygen consumption per 10® cells was not 
different in ob/ob and non-ob/ob mice (Fig. 6). However, O2 
consumption per dissectable brown fat pads in ob/ob mice was 
lower than that in non-ob/ob mice at all doses of T3. T3 
treatment increased brown adipocyte O2 consumption 
dramatically only in the non-ob/ob when expressed on a fat pad 
basis. The highest substrate induced O2 consumption was 
obtained with pyruvate. 
Figure 6 Brown adipocytes oxygen consumption per 10® cells 
and per dissectable fat pads in T3 treated ob/ob and non-ob/ob 
mice at 6 weeks of age. The mice were treated with T3 from 3 
to 6 weeks of age as outlined in Materials and Methods. 
Values are the means ± SEM for 10 mice per group. For O2 
consumption per 10® cells, the ANOVA showed a significant 
substrate effect at P < 0.0001. Mean square error is 
0.004389. For O2 consumption per dissectable fat pads, the 
ANOVA showed significant T3 effect at P < 0.0048, phenotype 
effect at P < 0.0001, T3 x phenotype effect at P < 0.0001, and 
substrate effect at P < 0.0001. Mean square error is 0.06724. 
Significant differences between means were determined by using 
the protected t-test. *significantly different from the 
corresponding 0.0 /xg T3/IOO g BW at P < 0.05, "^significantly 
different from non-ob/ob at P < 0.05, ^ significantly different 
from KRB at P < 0.05. 
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DISCUSSION 
By 5-6 weeks of age, the obese phenotype is readily 
apparent by visual inspection, and several metabolic 
abnormalities are present. The low metabolic rate (Kaplan and 
Leveille 1974) and abnormal temperature regulation (Joosten 
and Van der Kroon 1974) evident in preweaning ob/ob mice were 
likely to be the result of reduced circulating thyroid 
hormones reported by me (Oh and Kaplan 1993) and by others 
(Mobley and Dubuc 1979). Also, these mice had fewer liver T3 
receptors per unit DNA than did non-ob/ob at 2 weeks of age, 
which supports the likelihood that abnormal thyroid hormone 
action is an early defect (Khan et al. 1986). This early 
developmental period between 2 and 6 weeks of age might be a 
critical period in terms of changing metabolic aspects of 
obesity. In this study, the T3 treatment had significant 
effects on oxidative metabolism in skeletal muscles, brown 
adipose tissue, and liver of young ob/ob mice. 
The decrease in body weight in ob/ob mice (Table 1, 2, 3) 
after T3 treatment was due mostly to the decrease in body fat. 
Soleus and diaphragm muscle weights in saline-treated ob/ob 
mice were lower than those of saline-treated non-ob/ob mice 
(Table 1). Because skeletal muscle accounts for 40-50 % of 
body weight in normal weight human, it could be one of the 
most important metabolic masses (Owen et al. 1978). However, 
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overall T3 treatment did not significantly change muscle 
weight and muscle protein in ob/ob mice. 
As expected, epididymal fat pad weight and liver weight in 
ob/ob mice were greatly decreased after T3 treatment (Table 2, 
3). These changes in above tissue weight after T3 treatment 
agree with some of the work of others (Van der Kroon et al. 
1981) and with my own past work (unpublished 1993) which 
reported that total body fat content was decreased but total 
body protein content did not significantly change. Liver 
weight and relative liver weight in ob/ob mice were decreased 
after T3 treatment possibly by loss of fat content. Total 
liver protein and total number of hepatocytes were higher in 
saline-treated ob/ob mice due to the heavier liver (Table 2). 
T3 treatment during growth resulted in both lower hepatocyte 
number and liver protein only in ob/ob mice. This action of 
T3 on liver weight and hepatocyte numbers was previously 
unknown and to my knowledge is first reported here. 
The saline-treated ob/ob mice which were not hyperphagic 
still had larger epididymal fat deposits (Table 3) but had 
fewer adipocytes and larger cell sizes than did saline-treated 
non-ob/ob mice (Table 3, 4). This is different from studies 
in which the ob/ob mice are hyperphagic, which indicates that 
elevated adipocyte numbers are not necessary for early onset 
obesity. The earliest indicators of early onset obesity seem 
to be larger adipocyte size (Kaplan et al. 1980). T3 
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treatment resulted in significantly lower epididymal fat pad 
weight, adipocyte number, and average cell size in ob/ob mice, 
but these mice still had higher fat pad weights and larger 
cell sizes than did non-ob/ob mice. Van der Kroon et al. 
(1981) reported similar results after T4 treatment in that 
ob/ob mice receiving the same amount of food as non-ob/ob mice 
still had higher fat deposition. In the Zucker obese (fa/fa) 
rat, obesity also develops when hyperphagia is prevented 
(Berke and Kaplan 1983, Cleary et al. 1980). In adult ob/ob 
mice, the excessive body fat can be maintained without 
hyperphagia because of depressed energy expenditure (Himms-
Hagen 1983b, Pullar and Webster 1977). 
The cell size distribution of epididymal adipocytes was 
different between ob/ob and non-ob/ob mice. The ob/ob mice 
showed a bimodal distribution with more cells in the smaller 
(25-32 jum) and larger (80-100 /itm) ranges (Fig. 1) . This mode 
of cell distribution in ob/ob mice suggested that ob/ob mice 
were making more fat cells (smaller range) while filling fat 
cells that already exist with fats (larger range). Non-ob/ob 
mice had a unimodal distribution, having more cells in the 50-
63 jLcm range. T3 treatment shifted the distribution towards an 
increased number of smaller cells and a decreased number of 
larger cells with the peak range of the distribution in the 
ob/ob mice being in the 63-80 /xm range. In non-ob/ob mice, 
the peak was shifted to the 40-50 ixm range. These data are 
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consistent with the decreased body fat in both phenotypes due 
to T3 treatment. 
Brown adipose tissue was heavier in saline-treated ob/ob 
mice than in non-ob/ob mice. T3 treatment increased brown 
adipose tissue weight, brown adipocyte number, and average 
cell size in non-ob/ob mice but not in ob/ob mice (Table 3). 
Others reported that T4 treatment increased brown adipose 
tissue weight in lean but not in ob/ob mice (Knehans and 
Romsos 1984). Blouquit and Gripois (1990) reported that 
hypothyroid rats had lower brown adipose tissue weight than 
did euthyroid rats, and T3 treatment increased brown adipose 
tissue weight in hypothyroid rats. These data indicate that 
the brown adipose tissue in ob/ob mice does not respond to 
exogenous T3 as indicated by failure of brown adipocyte number 
and average cell size to change after the T3 treatment (Table 
3, 4). The cell size distribution of brown adipocytes showed 
more cells in smaller range in both ob/ob and non-ob/ob mice 
(Fig. 2). T3 treatment increased the distribution towards 
more large cells only in the non-ob/ob mice. These data are 
consistent with the action of T3 to increase brown adipose 
tissue weight, cell size, and number in non-ob/ob mice and 
support the concept of resistance to the action of T3 in brown 
adipose tissue of ob/ob mice. 
As previously mentioned, skeletal muscle mass is about 40-
50 % of body weight in normal human subjects (Owen et al. 
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1978) and accounts for at least 50 % of the whole body resting 
metabolic rate (Tzankoff and Norris 1977). The lower muscle 
weight in ob/ob mice together with the lower muscle O2 
consumption reported here (Fig. 3) as well as in past reports 
(Conway and Kaplan 1977, Kaplan and Oh 1991) may account for 
lower body O2 consumption (Kaplan and Leveille 1974, Oh and 
Kaplan 1989). Previously, I reported that T3 treatment 
increased both non-insulin-stimulated and insulin-stimulated 
glucose utilization in muscles from ob/ob and non-ob/ob mice 
(Oh and Kaplan 1989), but the ob/ob required higher T3 doses 
to achieve this stimulation. In the present study, T3 
treatment significantly increased non-insulin-stimulated and 
insulin-stimulated O2 consumption in ob/ob soleus and 
diaphragm muscles, and increased insulin sensitivity in ob/ob 
diaphragm muscle. Higher doses of T3 were required in the 
ob/ob to achieve levels similar with those in the non-ob/ob 
mice, which is consistent with the concept of T3 resistance by 
tissues of ob/ob mice. 
DeLuise and Barker (1989) reported that the genetically 
obese NZO mice had lower soleus muscle O2 consumption and 
lower Na*-K^-pump activity, which may contribute to the 
development of obesity. The activation of sympathetic nervous 
system may provide some link between increased Na^^K^-pump 
activity and energy expenditure by skeletal muscle. In 
humans, epinephrine-induced thermogenesis is minimal in brown 
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adipose tissue, which suggests that up to 50 % of the increase 
in whole body O2 consumption may take place in other tissues 
such as skeletal muscle (Astrup et al. 1985). Also, Blaak et 
al. (1993) reported that both and 82 adrenoceptors are 
involved in the sympathetically mediated thermogenesis whereas 
«1, «2' and B3 adrenoceptors do not play a role in the healthy 
human. Because the adrenoceptor population of skeletal muscle 
mainly consists of 62 receptors, skeletal muscle is probably 
an important site of localization of sympathetically mediated 
thermogenesis (Ligget et al. 1988). 
Hepatocyte O2 consumption per cell was not different 
between saline-treated ob/ob and non-ob/ob mice (Fig. 4) 
suggesting that the oxidative capability of ob/ob hepatocytes 
are the same as non-ob/ob hepatocytes. However, total liver 
O2 consumption in saline-treated ob/ob mice was higher than 
that of non-ob/ob due to the larger liver size and higher 
number of hepatocytes (Table 2). Higher liver O2 consumption 
in ob/ob mice may be the result of increased lipogenic 
activity. T3 treatment increased hepatocyte O2 consumption 
per cell in both phenotypes. The non-ob/ob mice were more 
sensitive to exogenous T3 and achieved higher level of 
respiration than did ob/ob mice. On a whole liver basis, O2 
consumption was decreased in ob/ob mice after T3 treatment 
mainly due to the decrease in liver weight. In the non-ob/ob 
mice, major changes in whole liver O2 consumption after T3 
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treatment were not evident except at very high doses of T3. 
After T3 treatment, no phenotypic differences between ob/ob 
and non-ob/ob mice were evident. McBride and Early (1989) 
reported that total O2 consumption of isolated hepatocytes was 
unaffected after T4 treatment in sheep, but ouabain-sensitive 
respiration was increased, suggesting that the involvement of 
Na"*"-K'^-ATPase in thyroid hormone-stimulated oxidative 
metabolism. Except for pyruvate, there was no substrate-
induced O2 consumption in hepatocytes from saline-treated 
mice. However, T3 treatment stimulated substrate-induced 
hepatocyte O2 consumption. This result agrees with the 
reports in which T3 increased substrate-induced (palmitate + 
lactate) O2 consumption in isolated rat hepatocytes (Gregory 
and Berry 1991). 
DeGroot et al. (1976) reported no relationship between T3 
receptors and thyroid status in the rat liver. However, it is 
reported that ob/ob mice had fewer receptors than did non-
ob/ob mice at all ages from 2 weeks through 18 weeks of age 
(Khan et al. 1986). Because the metabolic response to T3 
depends not only on the concentration of hormone but on the 
number of hormone receptors, ob/ob mice might have both lower 
thyroid hormone levels and fewer receptors than non-ob/ob 
mice. 
In the present study, T3 treatment increased hepatocyte O2 
consumption per cell, but total hepatocyte numbers were 
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decreased, resulting in no change in total liver O2 
consumption. The liver of ob/ob mice was not very responsive 
to exogenous T3. Hillgartner and Romsos (1988) reported that 
decreased hepatic thyroid hormone uptake may contribute to 
impaired thyroid hormone action in ob/ob mice, because hepatic 
T3 production contributes approximately 28 % of the 
intracellular T3 in liver. 
Epididymal adipocyte O2 consumptions per cell and per fat 
pad were lower in ob/ob mice than non-ob/ob mice at all doses 
of T3 (Fig. 5). There was no overall effect of T3 on 
epididymal adipocyte O2 consumption. Others report that white 
adipose tissue is a thyroid hormone-responsive tissue 
(Cronrath et al. 1988) , and T3 increased malic enzyme activity 
in expiants of human white adipose tissue (Rao et al. 1984). 
However, oxidative metabolism of white adipose tissue from 
ob/ob mice in this study was resistant to exogenous T3, which 
is consistent with the concept of tissue resistance to thyroid 
hormone in ob/ob mice. 
Brown adipocyte O2 consumption per cell was not different 
between ob/ob and non-ob/ob (Fig. 6), suggesting that the 
oxidative ability of ob/ob adipocytes are the same as non-
ob/ob adipocytes. Because ob/ob mice had heavier fat pads 
than did non-ob/ob but had the same number of cells (Table 3), 
O2 consumption per fat pad was lower than that of non-ob/ob 
mice. T3 treatment did not change ob/ob brown adipocyte O2 
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consumption because it did not change brown fat pad weight, 
cell number, and cell size. However, in non-ob/ob mice, brown 
fat pad O2 consumption increased dramatically after T3 
treatment (Fig. 6) due to the increase in the number of 
adipocytes (Table 3). Abelenda and Puerta (1990) reported 
that thyroid hormone did not affect brown adipose tissue 
significantly when thermogenic requirements are moderate, but 
participate in the trophic response when thermogenic 
requirements were intense. This might explain the lack of 
response of brown adipocyte to T3 in this study along with 
tissue resistance of ob/ob mice. The metabolic activity of 
brown adipose tissue is regulated by norepinephrine via its 
sympathetic innervation, and thyroid hormone enables the 
tissue to respond thermogenically to norepinephrine (Himms-
Hagen 1984). However, the capacity of these ob/ob mice to 
respond to norepinephrine by an increase in metabolic rate was 
reduced (Hogan and Himms-Hagen 1980), and cold-induced 
increase in brown adipose tissue thermogenesis was very small 
in ob/ob mice (Kates and Himms-Hagen 1990). Also, ob/ob mice 
were defective in Jî-adrenergic component (Kates et al. 1990). 
Although the sympathetic innervation of brown adipose tissue 
seems normal in ob/ob mice (Ashwell and Dunnett 1985), the 
brown adipose tissue in ob/ob mice may be refractory to 
norepinephrine or thyroid hormone. These are consistent with 
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our results that brown adipose tissue of ob/ob mice is 
resistant to T3. 
From this study, I can conclude that T3 treatment decreased 
body weight mostly by a lack of accumulation of body fat, and 
increased oxidative metabolism in metabolically important 
tissues studied, which were skeletal muscle, liver, and brown 
adipose tissue. In ob/ob mice, T3 treatment significantly 
decreased body weight along with body fat, but increased 
oxidative metabolism only in muscles, not in liver or brown 
adipose tissue. The action of T3 on ob/ob muscles required 
higher doses than in non-ob/ob mice. The data in the present 
report are consistent with the concept of T3 resistance by 
muscle and brown adipose tissue in ob/ob mice. The 
concomitant low circulating levels of thyroid hormones and the 
tissue resistance to T3 might be important early defects in 
this particular obesity syndrome. 
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Footnotes 
^AIN mineral mix 76, ICN Biomedicals, Costa Mesa, CA. 
Composition of nutrients per kg mineral mixture: calcium 
phosphate dibasic, 500 g; sodium chloride, 74 g; potassium 
citrate monohydrate, 220 g; potassium sulfate, 52 g; magnesium 
oxide, 24 g; manganous carbonate (43-48 % Mn), 3.5 g; ferric 
citrate (16-17 % Fe), 6 g; zinc carbonate (70 % ZnO), 1.6 g; 
cupric carbonate (53-55 % Cu), 0.3 g; potassium iodate, 0.01 
g; sodium selenite, 0.01 g; chromium potassium sulfate, 0.55 
g; sucrose, finely powdered, 118 g. 
^AIN vitamin mix 76, ICN Biomedicals, Costa Mesa, CA. 
Composition of nutrients per kg vitamin mixture: Thiamine-HCl, 
600 mg; riboflavin, 600 mg; pyridoxine HCl, 700 mg; nicotinic 
acid, 3.0 g; D-calcium pantothenate, 1.6 g; folic acid, 200 
mg; D-biotin, 20 mg; cyanocobalamine, 1.0 mg; retinyl 
palmitate (250,000 lU/g), 1.6 g; DL-alpha-tocopherol acetate 
(250 lU/g), 20 g; cholecalciferol (400,000 lU/g), 250 mg; 
Menaquinone, 5 mg; sucrose, finely powdered, 972.9 g. 
112 
GENERAL DISCUSSION AND SUMMARY 
In genetically obese hyperglycemic (ob/ob) mice, the early 
period of life, prior to gross deposition of fat, is probably 
critical to the development of the obese syndrome. By 5-6 
weeks of age, the obese phenotype is grossly apparent by 
visual inspection and several metabolic abnormalities are 
present. Genetic differences in some aspects of metabolism 
probably are present early and cause abnormal physiological 
function and subsequent expression of phenotype. The low 
metabolic rate (Kaplan and Leveille 1974) and abnormal 
temperature regulation (Joosten and Van der Kroon 1974) 
evident in preweaning ob/ob mice are likely to be the result 
of reduced circulating thyroid hormones reported by me in this 
dissertation and by others (Mobley and Dubuc 1979). Also, 
these mice had fewer liver T3 receptors per unit DNA than did 
non-ob/ob at 2 weeks of age and throughout the adulthood (Khan 
et al. 1986). This suggests the likelihood that abnormal 
thyroid hormone action is an early defect. This early 
developmental period between 2 and 6 weeks of age might be a 
critical period in terms of changing metabolic aspects of 
obesity. I proposed that this critical period might be 
113 
between 3 weeks of age, immediately after weaning, and 6 weeks 
of age when the obese phenotype is easily detectable. The 
possibilities were explored that an early T3 treatment in this 
critical period would improve oxidative metabolism and reduce 
body fat. 
The saline-treated ob/ob mice in these experiments clearly 
showed lower whole body oxygen consumption, lower tissue 
oxygen consumption in muscle and brown and white adipose 
tissues but higher oxygen consumption in liver, lower body 
temperature, lower concentrations of thyroid hormones (T4 and 
T3), and higher body fat at 6 weeks of age as compared with 
same parameter in saline-treated non-ob/ob mice. T3 treatment 
increased circulating T3 levels to within the normal range, 
increased animal O2 consumption, increased body temperature, 
and decreased body fat of young ob/ob mice without the change 
in total body protein. The equalized food consumption 
prevented gross obesity in ob/ob mice during experimental 
period. T3 treatment along with restricted food regimen 
further reduced circulating insulin and glucose level in ob/ob 
mice. 
Contradictory reports exist about concentrations of thyroid 
hormones in serum in ob/ob mice and whether the defects in 
metabolism reside in malfunction of pituitary-thyroid axis or 
insensitivity of extrathyroidal tissues to circulating 
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hormones. Pituitary secretion of TSH is regulated by negative 
feedback control by T4 and T3, and is the principal factor 
modifying thyroid activity. These experiments showed that 
ob/ob mice exhibit decreased serum T4 and T3 and increased TSH 
concentrations. Evidently, the pituitary secreted TSH in 
response to lower circulating levels of thyroid hormones but 
somehow the thyroid gland could not produce more T4 or T3. 
This lack of thyroid hormone production suggests that there 
might a defect either in the pituitary-thyroid axis (thyroid 
gland not responding to the TSH signal from the pituitary) or 
thyroid gland itself (dysfunctional hormone producing cells). 
Individual body composition may influence the whole body 
metabolism. T3 treatment decreased body weight mostly by a 
lack of accumulation of body fat. Because muscle tissues are 
metabolically more active than fat tissues, the abnormal ratio 
of protein to fat mass can explain the lower O2 consumption in 
the ob/ob mice. The increase in body O2 consumption after T3 
treatment without the increase in total body protein suggests 
that the lean body mass or high protein-containing tissues 
increased oxidative activity in response to T3 treatment. T3 
treatment increased oxidative metabolism in metabolically 
important tissues studied, which were skeletal muscle, liver, 
and brown adipose tissue of non-ob/ob mice. In ob/ob mice, T3 
treatment significantly decreased body weight along with body 
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fat, but increased oxidative metabolism only in muscle, not in 
liver or brown adipose tissue. The action of T3 on ob/ob 
muscles required higher doses than in non-ob/ob mice. The 
data in present dissertation are consistent with the concept 
of T3 resistance by muscle and brown adipose tissue in ob/ob 
mice. 
The concomitant low circulating levels of thyroid hormones 
and the tissue resistance to T3 might be important early 
defects in this particular obesity syndrome. The importance 
of these defects to the etiology of obesity is not clearly 
answered yet. This dissertation has furthered the 
understanding of the action of thyroid hormone on oxidative 
metabolism at the early stage of developing obesity in 
metabolically important tissues especially skeletal muscle and 
adipose tissues. Thyroid hormone action should be considered 
in the context of the total physiological setting of the 
animal because thyroid hormones interact with a large variety 
of hormonal and metabolic stimuli. 
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